KR20230069848A - Novel compound and organic light emitting device comprising the same - Google Patents

Novel compound and organic light emitting device comprising the same Download PDF

Info

Publication number
KR20230069848A
KR20230069848A KR1020220149170A KR20220149170A KR20230069848A KR 20230069848 A KR20230069848 A KR 20230069848A KR 1020220149170 A KR1020220149170 A KR 1020220149170A KR 20220149170 A KR20220149170 A KR 20220149170A KR 20230069848 A KR20230069848 A KR 20230069848A
Authority
KR
South Korea
Prior art keywords
compound
water
organic layer
stirred
added
Prior art date
Application number
KR1020220149170A
Other languages
Korean (ko)
Inventor
김민준
이동훈
서상덕
김영석
Original Assignee
주식회사 엘지화학
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 엘지화학 filed Critical 주식회사 엘지화학
Priority to CN202280031945.2A priority Critical patent/CN117222651A/en
Priority to PCT/KR2022/017711 priority patent/WO2023085835A1/en
Publication of KR20230069848A publication Critical patent/KR20230069848A/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • H10K85/622Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing four rings, e.g. pyrene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/654Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6574Polycyclic condensed heteroaromatic hydrocarbons comprising only oxygen in the heteroaromatic polycondensed ring system, e.g. cumarine dyes
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6576Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

The present invention provides a novel compound and an organic light emitting device using the same. The present invention provides a compound represented by chemical formula 1. The compound represented by chemical formula 1 can be used as a material for an organic layer of the organic light emitting device, and thus can improve efficiency, lower driving voltage, and/or improve lifespan characteristics of the organic light emitting device.

Description

신규한 화합물 및 이를 이용한 유기 발광 소자{Novel compound and organic light emitting device comprising the same}Novel compound and organic light emitting device using the same

본 발명은 신규한 화합물 및 이를 포함하는 유기 발광 소자에 관한 것이다. The present invention relates to a novel compound and an organic light emitting device including the same.

일반적으로 유기 발광 현상이란 유기 물질을 이용하여 전기에너지를 빛에너지로 전환시켜주는 현상을 말한다. 유기 발광 현상을 이용하는 유기 발광 소자는 넓은 시야각, 우수한 콘트라스트, 빠른 응답 시간을 가지며, 휘도, 구동 전압 및 응답 속도 특성이 우수하여 많은 연구가 진행되고 있다. In general, the organic light emitting phenomenon refers to a phenomenon in which electrical energy is converted into light energy using an organic material. An organic light emitting device using an organic light emitting phenomenon has a wide viewing angle, excellent contrast, and a fast response time, and has excellent luminance, driving voltage, and response speed characteristics, and thus many studies are being conducted.

유기 발광 소자는 일반적으로 양극과 음극 및 상기 양극과 음극 사이에 유기물 층을 포함하는 구조를 가진다. 상기 유기물 층은 유기 발광 소자의 효율과 안정성을 높이기 위하여 각기 다른 물질로 구성된 다층의 구조로 이루어진 경우가 많으며, 예컨대 정공주입층, 정공수송층, 발광층, 전자수송층, 전자주입층 등으로 이루어질 수 있다. 이러한 유기 발광 소자의 구조에서 두 전극 사이에 전압을 걸어주게 되면 양극에서는 정공이, 음극에서는 전자가 유기물층에 주입되게 되고, 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 다시 바닥상태로 떨어질 때 빛이 나게 된다. An organic light emitting device generally has a structure including an anode, a cathode, and an organic material layer between the anode and the cathode. In order to increase the efficiency and stability of the organic light emitting device, the organic material layer is often composed of a multi-layered structure composed of different materials, and may include, for example, a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and an electron injection layer. In the structure of this organic light emitting device, when a voltage is applied between the two electrodes, holes are injected from the anode and electrons from the cathode are injected into the organic material layer, and when the injected holes and electrons meet, excitons are formed. When it falls back to the ground state, it glows.

상기와 같은 유기 발광 소자에 사용되는 유기물에 대하여 새로운 재료의 개발이 지속적으로 요구되고 있다.The development of new materials for organic materials used in the organic light emitting device as described above is continuously required.

한국특허 공개번호 제10-2000-0051826호Korean Patent Publication No. 10-2000-0051826

본 발명은 신규한 화합물 및 이를 포함하는 유기 발광 소자에 관한 것이다. The present invention relates to a novel compound and an organic light emitting device including the same.

본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다:The present invention provides a compound represented by Formula 1 below:

[화학식 1][Formula 1]

Figure pat00001
Figure pat00001

상기 화학식 1에서, In Formula 1,

X1 내지 X10 중 하나는 N이고, 다른 하나는 하기 화학식 2의 치환기가 치환된 C이고, 나머지는 CR1이고, One of X 1 to X 10 is N, the other is C substituted with a substituent represented by Formula 2 below, and the others are CR 1 ;

R1은 각각 독립적으로 수소, 또는 중수소이고, R 1 is each independently hydrogen or deuterium;

[화학식 2][Formula 2]

Figure pat00002
Figure pat00002

상기 화학식 2에서, In Formula 2,

Y는 각각 독립적으로 N, 또는 CR2이고, 단 Y 중 적어도 하나는 N이고, Y is each independently N or CR 2 , provided that at least one of Y is N;

R2는 각각 독립적으로 수소, 또는 중수소이고, R 2 are each independently hydrogen or deuterium;

L은 단일 결합, 또는 치환 또는 비치환된 C6-60 아릴렌이고,L is a single bond or a substituted or unsubstituted C 6-60 arylene;

L1 및 L2는 각각 독립적으로 단일 결합, 또는 치환 또는 비치환된 C6-60 아릴렌이고,L 1 and L 2 are each independently a single bond or a substituted or unsubstituted C 6-60 arylene;

Ar1 및 Ar2는 각각 독립적으로 치환 또는 비치환된 C6-60 아릴, 또는 치환 또는 비치환된 N, O 및 S로 구성되는 군으로부터 선택되는 어느 하나 이상을 포함하는 C2-60 헤테로아릴이고,Ar 1 and Ar 2 are each independently a substituted or unsubstituted C 6-60 aryl, or a substituted or unsubstituted C 2-60 heteroaryl containing at least one selected from the group consisting of N, O and S; ego,

단, X5 또는 X6가 N이면, X1 내지 X4 및 X7 내지 X10 중 하나가 상기 화학식 2의 치환기가 치환된 C이고, However, when X 5 or X 6 is N, one of X 1 to X 4 and X 7 to X 10 is C substituted with the substituent of Formula 2,

X7 내지 X10 중 하나가 N이면, X1 내지 X6 중 하나가 상기 화학식 2의 치환기가 치환된 C이다. When one of X 7 to X 10 is N, one of X 1 to X 6 is C substituted with the substituent of Formula 2 above.

또한, 본 발명은 제1 전극; 상기 제1 전극과 대향하여 구비된 제2 전극; 및 상기 제1 전극과 상기 제2 전극 사이에 구비된 1층 이상의 유기물 층을 포함하는 유기 발광 소자로서, 상기 유기물층 중 1층 이상은 상기 화학식 1로 표시되는 화합물을 포함하는, 유기 발광 소자를 제공한다.In addition, the present invention is a first electrode; a second electrode provided to face the first electrode; and one or more organic material layers provided between the first electrode and the second electrode, wherein at least one of the organic material layers includes the compound represented by Chemical Formula 1. do.

상술한 화학식 1로 표시되는 화합물은 유기 발광 소자의 유기물 층의 재료로서 사용될 수 있으며, 유기 발광 소자에서 효율의 향상, 낮은 구동전압 및/또는 수명 특성을 향상시킬 수 있다. 특히, 상술한 화학식 1로 표시되는 화합물은 정공주입, 정공수송, 정공주입 및 수송, 발광, 전자수송, 또는 전자주입 재료로 사용될 수 있다.The compound represented by Chemical Formula 1 may be used as a material for an organic layer of an organic light emitting diode, and may improve efficiency, low driving voltage, and/or lifespan characteristics of an organic light emitting diode. In particular, the compound represented by Chemical Formula 1 may be used as a material for hole injection, hole transport, hole injection and transport, light emission, electron transport, or electron injection.

도 1은 기판(1), 양극(2), 발광층(3), 음극(4)으로 이루어진 유기 발광 소자의 예를 도시한 것이다.
도 2는 기판(1), 양극(2), 정공주입층(5), 정공수송층(6), 전자차단층(7), 발광층(3), 정공저지층(8), 전자주입 및 수송층(9) 및 음극(4)로 이루어진 유기 발광 소자의 예를 도시한 것이다.
1 shows an example of an organic light emitting device composed of a substrate 1, an anode 2, a light emitting layer 3, and a cathode 4.
2 shows a substrate 1, an anode 2, a hole injection layer 5, a hole transport layer 6, an electron blocking layer 7, a light emitting layer 3, a hole blocking layer 8, an electron injection and transport layer ( 9) and an example of an organic light emitting element composed of a cathode 4 is shown.

이하, 본 발명의 이해를 돕기 위하여 보다 상세히 설명한다.Hereinafter, in order to aid understanding of the present invention, it will be described in more detail.

본 명세서에서,

Figure pat00003
또는
Figure pat00004
는 다른 치환기에 연결되는 결합을 의미한다. In this specification,
Figure pat00003
or
Figure pat00004
means a bond connected to another substituent.

본 명세서에서 "치환 또는 비치환된" 이라는 용어는 중수소; 할로겐기; 니트릴기; 니트로기; 히드록시기; 카보닐기; 에스테르기; 이미드기; 아미노기; 포스핀옥사이드기; 알콕시기; 아릴옥시기; 알킬티옥시기; 아릴티옥시기; 알킬술폭시기; 아릴술폭시기; 실릴기; 붕소기; 알킬기; 사이클로알킬기; 알케닐기; 아릴기; 아르알킬기; 아르알케닐기; 알킬아릴기; 알킬아민기; 아랄킬아민기; 헤테로아릴아민기; 아릴아민기; 아릴포스핀기; 또는 N, O 및 S 원자 중 1개 이상을 포함하는 헤테로고리기로 이루어진 군에서 선택된 1개 이상의 치환기로 치환 또는 비치환되거나, 상기 예시된 치환기 중 2 이상의 치환기가 연결된 치환 또는 비치환된 것을 의미한다. 예컨대, "2 이상의 치환기가 연결된 치환기"는 비페닐기일 수 있다. 즉, 비페닐기는 아릴기일 수도 있고, 2개의 페닐기가 연결된 치환기로 해석될 수 있다.In this specification, the term "substituted or unsubstituted" means deuterium; halogen group; nitrile group; nitro group; hydroxy group; carbonyl group; ester group; imide group; amino group; phosphine oxide group; alkoxy group; aryloxy group; Alkyl thioxy group; Arylthioxy group; an alkyl sulfoxy group; aryl sulfoxy group; silyl group; boron group; an alkyl group; cycloalkyl group; alkenyl group; aryl group; aralkyl group; Aralkenyl group; Alkyl aryl group; Alkylamine group; Aralkylamine group; heteroarylamine group; Arylamine group; Arylphosphine group; Or substituted or unsubstituted with one or more substituents selected from the group consisting of a heterocyclic group containing at least one of N, O, and S atoms, or substituted or unsubstituted with two or more substituents linked to each other among the substituents exemplified above. . For example, "a substituent in which two or more substituents are connected" may be a biphenyl group. That is, the biphenyl group may be an aryl group, and may be interpreted as a substituent in which two phenyl groups are connected.

본 명세서에서 카보닐기의 탄소수는 특별히 한정되지 않으나, 탄소수 1 내지 40인 것이 바람직하다. 구체적으로 하기와 같은 구조의 치환기가 될 수 있으나, 이에 한정되는 것은 아니다.In the present specification, the number of carbon atoms of the carbonyl group is not particularly limited, but is preferably 1 to 40 carbon atoms. Specifically, it may be a substituent having the following structure, but is not limited thereto.

Figure pat00005
Figure pat00005

본 명세서에 있어서, 에스테르기는 에스테르기의 산소가 탄소수 1 내지 25의 직쇄, 분지쇄 또는 고리쇄 알킬기 또는 탄소수 6 내지 25의 아릴기로 치환될 수 있다. 구체적으로, 하기 구조식의 치환기가 될 수 있으나, 이에 한정되는 것은 아니다.In the present specification, the ester group may be substituted with an aryl group having 6 to 25 carbon atoms or a straight-chain, branched-chain or cyclic chain alkyl group having 1 to 25 carbon atoms in the ester group. Specifically, it may be a substituent of the following structural formula, but is not limited thereto.

Figure pat00006
Figure pat00006

본 명세서에 있어서, 이미드기의 탄소수는 특별히 한정되지 않으나, 탄소수 1 내지 25인 것이 바람직하다. 구체적으로 하기와 같은 구조의 치환기가 될 수 있으나, 이에 한정되는 것은 아니다.In the present specification, the number of carbon atoms of the imide group is not particularly limited, but is preferably 1 to 25 carbon atoms. Specifically, it may be a substituent having the following structure, but is not limited thereto.

Figure pat00007
Figure pat00007

본 명세서에 있어서, 실릴기는 구체적으로 트리메틸실릴기, 트리에틸실릴기, t-부틸디메틸실릴기, 비닐디메틸실릴기, 프로필디메틸실릴기, 트리페닐실릴기, 디페닐실릴기, 페닐실릴기 등이 있으나 이에 한정되지 않는다. In the present specification, the silyl group is specifically a trimethylsilyl group, a triethylsilyl group, a t-butyldimethylsilyl group, a vinyldimethylsilyl group, a propyldimethylsilyl group, a triphenylsilyl group, a diphenylsilyl group, a phenylsilyl group, and the like. but not limited to

본 명세서에 있어서, 할로겐기의 예로는 불소, 염소, 브롬 또는 요오드가 있다.In this specification, examples of the halogen group include fluorine, chlorine, bromine or iodine.

본 명세서에 있어서, 상기 알킬기는 직쇄 또는 분지쇄일 수 있고, 탄소수는 특별히 한정되지 않으나 1 내지 40인 것이 바람직하다. 일 실시상태에 따르면, 상기 알킬기의 탄소수는 1 내지 20이다. 또 하나의 실시상태에 따르면, 상기 알킬기의 탄소수는 1 내지 10이다. 또 하나의 실시상태에 따르면, 상기 알킬기의 탄소수는 1 내지 6이다. 알킬기의 구체적인 예로는 메틸, 에틸, 프로필, n-프로필, 이소프로필, 부틸, n-부틸, 이소부틸, tert-부틸, sec-부틸, 1-메틸-부틸, 1-에틸-부틸, 펜틸, n-펜틸, 이소펜틸, 네오펜틸, tert-펜틸, 헥실, n-헥실, 1-메틸펜틸, 2-메틸펜틸, 4-메틸-2-펜틸, 3,3-디메틸부틸, 2-에틸부틸, 헵틸, n-헵틸, 1-메틸헥실, 사이클로펜틸메틸,사이클로헥틸메틸, 옥틸, n-옥틸, tert-옥틸, 1-메틸헵틸, 2-에틸헥실, 2-프로필펜틸, n-노닐, 2,2-디메틸헵틸, 1-에틸-프로필, 1,1-디메틸-프로필, 이소헥실, 2-메틸펜틸, 4-메틸헥실, 5-메틸헥실 등이 있으나, 이들에 한정되지 않는다.In the present specification, the alkyl group may be straight-chain or branched-chain, and the number of carbon atoms is not particularly limited, but is preferably 1 to 40. According to one embodiment, the number of carbon atoms of the alkyl group is 1 to 20. According to another exemplary embodiment, the number of carbon atoms of the alkyl group is 1 to 10. According to another exemplary embodiment, the alkyl group has 1 to 6 carbon atoms. Specific examples of the alkyl group include methyl, ethyl, propyl, n-propyl, isopropyl, butyl, n-butyl, isobutyl, tert-butyl, sec-butyl, 1-methyl-butyl, 1-ethyl-butyl, pentyl, n -pentyl, isopentyl, neopentyl, tert-pentyl, hexyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 4-methyl-2-pentyl, 3,3-dimethylbutyl, 2-ethylbutyl, heptyl , n-heptyl, 1-methylhexyl, cyclopentylmethyl, cyclohexylmethyl, octyl, n-octyl, tert-octyl, 1-methylheptyl, 2-ethylhexyl, 2-propylpentyl, n-nonyl, 2,2 -Dimethylheptyl, 1-ethyl-propyl, 1,1-dimethyl-propyl, isohexyl, 2-methylpentyl, 4-methylhexyl, 5-methylhexyl, etc., but is not limited thereto.

본 명세서에 있어서, 상기 알케닐기는 직쇄 또는 분지쇄일 수 있고, 탄소수는 특별히 한정되지 않으나, 2 내지 40인 것이 바람직하다. 일 실시상태에 따르면, 상기 알케닐기의 탄소수는 2 내지 20이다. 또 하나의 실시상태에 따르면, 상기 알케닐기의 탄소수는 2 내지 10이다. 또 하나의 실시상태에 따르면, 상기 알케닐기의 탄소수는 2 내지 6이다. 구체적인 예로는 비닐, 1-프로페닐, 이소프로페닐, 1-부테닐, 2-부테닐, 3-부테닐, 1-펜테닐, 2-펜테닐, 3-펜테닐, 3-메틸-1-부테닐, 1,3-부타디에닐, 알릴, 1-페닐비닐-1-일, 2-페닐비닐-1-일, 2,2-디페닐비닐-1-일, 2-페닐-2-(나프틸-1-일)비닐-1-일, 2,2-비스(디페닐-1-일)비닐-1-일, 스틸베닐기, 스티레닐기 등이 있으나 이들에 한정되지 않는다.In the present specification, the alkenyl group may be linear or branched, and the number of carbon atoms is not particularly limited, but is preferably 2 to 40. According to one embodiment, the alkenyl group has 2 to 20 carbon atoms. According to another exemplary embodiment, the alkenyl group has 2 to 10 carbon atoms. According to another exemplary embodiment, the alkenyl group has 2 to 6 carbon atoms. Specific examples include vinyl, 1-propenyl, isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 3-methyl-1- Butenyl, 1,3-butadienyl, allyl, 1-phenylvinyl-1-yl, 2-phenylvinyl-1-yl, 2,2-diphenylvinyl-1-yl, 2-phenyl-2-( naphthyl-1-yl)vinyl-1-yl, 2,2-bis(diphenyl-1-yl)vinyl-1-yl, stilbenyl group, styrenyl group, etc., but is not limited thereto.

본 명세서에 있어서, 사이클로알킬기는 특별히 한정되지 않으나, 탄소수 3 내지 60인 것이 바람직하며, 일 실시상태에 따르면, 상기 사이클로알킬기의 탄소수는 3 내지 30이다. 또 하나의 실시상태에 따르면, 상기 사이클로알킬기의 탄소수는 3 내지 20이다. 또 하나의 실시상태에 따르면, 상기 사이클로알킬기의 탄소수는 3 내지 6이다. 구체적으로 사이클로프로필, 사이클로부틸, 사이클로펜틸, 3-메틸사이클로펜틸, 2,3-디메틸사이클로펜틸, 사이클로헥실, 3-메틸사이클로헥실, 4-메틸사이클로헥실, 2,3-디메틸사이클로헥실, 3,4,5-트리메틸사이클로헥실, 4-tert-부틸사이클로헥실, 사이클로헵틸, 사이클로옥틸 등이 있으나, 이에 한정되지 않는다.In the present specification, the cycloalkyl group is not particularly limited, but preferably has 3 to 60 carbon atoms, and according to an exemplary embodiment, the cycloalkyl group has 3 to 30 carbon atoms. According to another exemplary embodiment, the number of carbon atoms of the cycloalkyl group is 3 to 20. According to another exemplary embodiment, the number of carbon atoms of the cycloalkyl group is 3 to 6. Specifically, cyclopropyl, cyclobutyl, cyclopentyl, 3-methylcyclopentyl, 2,3-dimethylcyclopentyl, cyclohexyl, 3-methylcyclohexyl, 4-methylcyclohexyl, 2,3-dimethylcyclohexyl, 3, 4,5-trimethylcyclohexyl, 4-tert-butylcyclohexyl, cycloheptyl, cyclooctyl, and the like, but are not limited thereto.

본 명세서에 있어서, 아릴기는 특별히 한정되지 않으나 탄소수 6 내지 60인 것이 바람직하며, 단환식 아릴기 또는 다환식 아릴기일 수 있다. 일 실시상태에 따르면, 상기 아릴기의 탄소수는 6 내지 30이다. 일 실시상태에 따르면, 상기 아릴기의 탄소수는 6 내지 20이다. 상기 아릴기가 단환식 아릴기로는 페닐기, 바이페닐기, 터페닐기 등이 될 수 있으나, 이에 한정되는 것은 아니다. 상기 다환식 아릴기로는 나프틸기, 안트라세닐기, 페난트릴기, 파이레닐기, 페릴레닐기, 크라이세닐기, 플루오레닐기 등이 될 수 있으나, 이에 한정되는 것은 아니다.In the present specification, the aryl group is not particularly limited, but preferably has 6 to 60 carbon atoms, and may be a monocyclic aryl group or a polycyclic aryl group. According to one embodiment, the number of carbon atoms of the aryl group is 6 to 30. According to one embodiment, the number of carbon atoms of the aryl group is 6 to 20. The aryl group may be a phenyl group, a biphenyl group, a terphenyl group, etc. as a monocyclic aryl group, but is not limited thereto. The polycyclic aryl group may be a naphthyl group, anthracenyl group, phenanthryl group, pyrenyl group, perylenyl group, chrysenyl group, fluorenyl group, and the like, but is not limited thereto.

본 명세서에 있어서, 플루오레닐기는 치환될 수 있고, 치환기 2개가 서로 결합하여 스피로 구조를 형성할 수 있다. 상기 플루오레닐기가 치환되는 경우,

Figure pat00008
등이 될 수 있다. 다만, 이에 한정되는 것은 아니다.In the present specification, the fluorenyl group may be substituted, and two substituents may be bonded to each other to form a spiro structure. When the fluorenyl group is substituted,
Figure pat00008
etc. However, it is not limited thereto.

본 명세서에 있어서, 헤테로고리기는 이종 원소로 O, N, Si 및 S 중 1개 이상을 포함하는 헤테로고리기로서, 탄소수는 특별히 한정되지 않으나, 탄소수 2 내지 60인 것이 바람직하다. 헤테로고리기의 예로는 티오펜기, 퓨란기, 피롤기, 이미다졸기, 티아졸기, 옥사졸기, 옥사디아졸기, 트리아졸기, 피리딜기, 비피리딜기, 피리미딜기, 트리아진기, 아크리딜기, 피리다진기, 피라지닐기, 퀴놀리닐기, 퀴나졸린기, 퀴녹살리닐기, 프탈라지닐기, 피리도 피리미디닐기, 피리도 피라지닐기, 피라지노 피라지닐기, 이소퀴놀린기, 인돌기, 카바졸기, 벤조옥사졸기, 벤조이미다졸기, 벤조티아졸기, 벤조카바졸기, 벤조티오펜기, 디벤조티오펜기, 벤조퓨라닐기, 페난쓰롤린기(phenanthroline), 이소옥사졸릴기, 티아디아졸릴기, 페노티아지닐기 및 디벤조퓨라닐기 등이 있으나, 이들에만 한정되는 것은 아니다.In the present specification, the heterocyclic group is a heterocyclic group containing at least one of O, N, Si, and S as heterogeneous elements, and the number of carbon atoms is not particularly limited, but preferably has 2 to 60 carbon atoms. Examples of the heterocyclic group include a thiophene group, a furan group, a pyrrole group, an imidazole group, a thiazole group, an oxazole group, an oxadiazole group, a triazole group, a pyridyl group, a bipyridyl group, a pyrimidyl group, a triazine group, and an acridyl group. , pyridazine group, pyrazinyl group, quinolinyl group, quinazoline group, quinoxalinyl group, phthalazinyl group, pyridopyrimidinyl group, pyridopyrazinyl group, pyrazinopyrazinyl group, isoquinoline group, indole group , carbazole group, benzoxazole group, benzoimidazole group, benzothiazole group, benzocarbazole group, benzothiophene group, dibenzothiophene group, benzofuranyl group, phenanthroline group, isoxazolyl group, thiadia A zolyl group, a phenothiazinyl group, and a dibenzofuranyl group, but are not limited thereto.

본 명세서에 있어서, 아르알킬기, 아르알케닐기, 알킬아릴기, 아릴아민기 중의 아릴기는 전술한 아릴기의 예시와 같다. 본 명세서에 있어서, 아르알킬기, 알킬아릴기, 알킬아민기 중 알킬기는 전술한 알킬기의 예시와 같다. 본 명세서에 있어서, 헤테로아릴아민 중 헤테로아릴은 전술한 헤테로고리기에 관한 설명이 적용될 수 있다. 본 명세서에 있어서, 아르알케닐기 중 알케닐기는 전술한 알케닐기의 예시와 같다. 본 명세서에 있어서, 아릴렌은 2가기인 것을 제외하고는 전술한 아릴기에 관한 설명이 적용될 수 있다. 본 명세서에 있어서, 헤테로아릴렌은 2가기인 것을 제외하고는 전술한 헤테로고리기에 관한 설명이 적용될 수 있다. 본 명세서에 있어서, 탄화수소 고리는 1가기가 아니고, 2개의 치환기가 결합하여 형성한 것을 제외하고는 전술한 아릴기 또는 사이클로알킬기에 관한 설명이 적용될 수 있다. 본 명세서에 있어서, 헤테로고리는 1가기가 아니고, 2개의 치환기가 결합하여 형성한 것을 제외하고는 전술한 헤테로고리기에 관한 설명이 적용될 수 있다.In the present specification, an aralkyl group, an aralkenyl group, an alkylaryl group, and an aryl group among arylamine groups are the same as the examples of the aryl group described above. In the present specification, the alkyl group among the aralkyl group, the alkylaryl group, and the alkylamine group is the same as the examples of the above-mentioned alkyl group. In the present specification, the description of the heterocyclic group described above may be applied to the heteroaryl of the heteroarylamine. In the present specification, the alkenyl group among the aralkenyl groups is the same as the examples of the alkenyl group described above. In the present specification, the description of the aryl group described above may be applied except that the arylene is a divalent group. In the present specification, the description of the heterocyclic group described above may be applied except that the heteroarylene is a divalent group. In the present specification, the hydrocarbon ring is not a monovalent group, and the description of the aryl group or cycloalkyl group described above may be applied, except that the hydrocarbon ring is formed by combining two substituents. In the present specification, the heterocyclic group is not a monovalent group, and the description of the above-described heterocyclic group may be applied, except that it is formed by combining two substituents.

상기 화학식 1에서, 하나 이상의 수소는 중수소로 치환될 수 있다. In Formula 1, one or more hydrogens may be substituted with deuterium.

바람직하게는, Y는 모두 N이다. Preferably, Y is all N.

바람직하게는, 상기 화학식 1은 하기 화학식 1-1 내지 1-10 중 어느 하나로 표시된다:Preferably, Formula 1 is represented by any one of Formulas 1-1 to 1-10 below:

Figure pat00009
Figure pat00009

상기 화학식 1-1에서, X2 내지 X10 중 하나는 상기 화학식 2의 치환기가 치환된 C이고, 나머지는 각각 독립적으로 CH 또는 CD이고,In Formula 1-1, one of X 2 to X 10 is C substituted with a substituent of Formula 2, and the others are each independently CH or CD,

상기 화학식 1-2에서, X1 및 X3 내지 X10 중 하나는 상기 화학식 2의 치환기가 치환된 C이고, 나머지는 각각 독립적으로 CH 또는 CD이고,In Formula 1-2, one of X 1 and X 3 to X 10 is C substituted with a substituent of Formula 2, and the others are each independently CH or CD,

상기 화학식 1-3에서, X1, X2 및 X4 내지 X10 중 하나는 상기 화학식 2의 치환기가 치환된 C이고, 나머지는 각각 독립적으로 CH 또는 CD이고,In Formula 1-3, one of X 1 , X 2 and X 4 to X 10 is C substituted with a substituent of Formula 2, and the others are each independently CH or CD,

상기 화학식 1-4에서, X1 내지 X3 및 X5 내지 X10 중 하나는 상기 화학식 2의 치환기가 치환된 C이고, 나머지는 각각 독립적으로 CH 또는 CD이고,In Formula 1-4, one of X 1 to X 3 and X 5 to X 10 is C substituted with a substituent of Formula 2, and the others are each independently CH or CD,

상기 화학식 1-5에서, X1 내지 X4 및 X7 내지 X10 중 하나는 상기 화학식 2의 치환기가 치환된 C이고, 나머지는 각각 독립적으로 CH 또는 CD이고, X6은 CH 또는 CD이고,In Formula 1-5, one of X 1 to X 4 and X 7 to X 10 is C substituted with a substituent of Formula 2, the others are each independently CH or CD, X 6 is CH or CD,

상기 화학식 1-6에서, X1 내지 X4 및 X7 내지 X10 중 하나는 상기 화학식 2의 치환기가 치환된 C이고, 나머지는 각각 독립적으로 CH 또는 CD이고, X5는 CH 또는 CD이고,In Formula 1-6, one of X 1 to X 4 and X 7 to X 10 is C substituted with a substituent of Formula 2, the others are each independently CH or CD, X 5 is CH or CD,

상기 화학식 1-7에서, X1 내지 X6 중 하나는 상기 화학식 2의 치환기가 치환된 C이고, 나머지는 각각 독립적으로 CH 또는 CD이고, X8 내지 X10은 각각 독립적으로 CH 또는 CD이고,In Formula 1-7, one of X 1 to X 6 is C substituted with a substituent of Formula 2, the others are each independently CH or CD, and X 8 to X 10 are each independently CH or CD,

상기 화학식 1-8에서, X1 내지 X6 중 하나는 상기 화학식 2의 치환기가 치환된 C이고, 나머지는 각각 독립적으로 CH 또는 CD이고, X7, X9 및 X10은 각각 독립적으로 CH 또는 CD이고,In Formula 1-8, one of X 1 to X 6 is C substituted with a substituent of Formula 2, the others are each independently CH or CD, and X 7 , X 9 and X 10 are each independently CH or is a CD,

상기 화학식 1-9에서, X1 내지 X6 중 하나는 상기 화학식 2의 치환기가 치환된 C이고, 나머지는 각각 독립적으로 CH 또는 CD이고, X7, X8 및 X10은 각각 독립적으로 CH 또는 CD이고,In Formula 1-9, one of X 1 to X 6 is C substituted with a substituent of Formula 2, the others are each independently CH or CD, and X 7 , X 8 and X 10 are each independently CH or is a CD,

상기 화학식 1-10에서, X1 내지 X6 중 하나는 상기 화학식 2의 치환기가 치환된 C이고, 나머지는 각각 독립적으로 CH 또는 CD이고, X7 내지 X9는 각각 독립적으로 CH 또는 CD이다.In Formula 1-10, one of X 1 to X 6 is C substituted with a substituent of Formula 2, the others are each independently CH or CD, and X 7 to X 9 are each independently CH or CD.

바람직하게는, L은 단일 결합, 비치환되거나 또는 하나 이상의 중수소로 치환된 페닐렌, 또는 비치환되거나 또는 하나 이상의 중수소로 치환된 나프틸렌이다. 보다 바람직하게는, L은 단일 결합, 1,4-페닐렌, 1,3-페닐렌, 1,2-페닐렌, 1,4-나프틸렌, 1,3-나프틸렌, 1,5-나프틸렌, 또는 1,6-나프틸렌이고, 여기서 L은 적어도 하나의 중수소로 치환될 수 있다. Preferably, L is a single bond, unsubstituted or substituted with one or more deuterium phenylene, or unsubstituted or substituted with one or more deuterium naphthylene. More preferably, L is a single bond, 1,4-phenylene, 1,3-phenylene, 1,2-phenylene, 1,4-naphthylene, 1,3-naphthylene, 1,5-naphthylene ethylene, or 1,6-naphthylene, where L may be substituted with at least one deuterium.

바람직하게는, L1 및 L2는 각각 독립적으로 단일 결합, 비치환되거나 또는 하나 이상의 중수소로 치환된 페닐렌, 또는 비치환되거나 또는 하나 이상의 중수소로 치환된 나프틸렌이다. 보다 바람직하게는, L1 및 L2는 각각 독립적으로 단일 결합, 1,4-페닐렌, 1,3-페닐렌, 1,2-페닐렌, 1,4-나프틸렌, 1,3-나프틸렌, 1,5-나프틸렌, 또는 1,6-나프틸렌이고, 여기서 L은 적어도 하나의 중수소로 치환될 수 있다. Preferably, L 1 and L 2 are each independently a single bond, unsubstituted or substituted with one or more deuterium phenylene, or unsubstituted or one or more deuterium substituted naphthylene. More preferably, L 1 and L 2 are each independently a single bond, 1,4-phenylene, 1,3-phenylene, 1,2-phenylene, 1,4-naphthylene, 1,3-naphthylene ethylene, 1,5-naphthylene, or 1,6-naphthylene, wherein L may be substituted with at least one deuterium.

바람직하게는, Ar1 및 Ar2는 각각 독립적으로 페닐, 비페닐릴, 터페닐릴, 나프틸, (페닐)나프틸, (나프틸)페닐, 페난쓰레닐, 벤조페난쓰레닐, 디벤조퓨라닐, 디벤조티오페닐, 카바졸-9-일, 또는 9-페닐-카바졸릴이고, 이때 상기 Ar1 및 Ar2는 각각 독립적으로 비치환되거나 또는 적어도 하나의 중수소로 치환된다. 한편, 상기 벤조페난쓰레닐은, 벤조[a]페난쓰레닐, 벤조[b]페난쓰레닐, 또는 벤조[c]페난쓰레닐을 포함한다. Preferably, Ar 1 and Ar 2 are each independently selected from phenyl, biphenylyl, terphenylyl, naphthyl, (phenyl)naphthyl, (naphthyl)phenyl, phenanthrenyl, benzophenanthrenyl, dibenzofuran Ranyl, dibenzothiophenyl, carbazol-9-yl, or 9-phenyl-carbazolyl, wherein Ar 1 and Ar 2 are each independently unsubstituted or substituted with at least one deuterium. Meanwhile, the benzophenanthrenyl includes benzo[a]phenanthrenyl, benzo[b]phenanthrenyl, or benzo[c]phenanthrenyl.

상기 화학식 1로 표시되는 화합물의 대표적인 예는 하기와 같다:Representative examples of the compound represented by Formula 1 are as follows:

Figure pat00010
Figure pat00010

Figure pat00011
Figure pat00011

Figure pat00012
Figure pat00012

Figure pat00013
Figure pat00013

Figure pat00014
Figure pat00014

Figure pat00015
Figure pat00015

Figure pat00016
Figure pat00016

Figure pat00017
Figure pat00017

Figure pat00018
Figure pat00018

Figure pat00019
Figure pat00019

Figure pat00020
Figure pat00020

상기 화학식 1로 표시되는 화합물 중 X1이 N이고, X2가 상기 화학식 2로 표시되는 치환기가 치환된 C이고, 나머지는 CR1인 경우, 일례로 하기 반응식 1과 같은 제조 방법으로 제조할 수 있으며, 그 외 나머지 화합물도 유사하게 제조할 수 있다.Among the compounds represented by Formula 1, when X 1 is N, X 2 is C substituted with a substituent represented by Formula 2, and the others are CR 1 , for example, it can be prepared by a manufacturing method as shown in Scheme 1 below. and other compounds can be similarly prepared.

[반응식 1][Scheme 1]

Figure pat00021
Figure pat00021

상기 반응식 1에서, Z를 제외한 나머지는 앞서 정의한 바와 같으며, Z는 할로겐이고, 바람직하게는 브로모 또는 클로로이다.In Scheme 1, everything except Z is as defined above, and Z is halogen, preferably bromo or chloro.

상기 반응은 팔라듐 촉매와 염기 존재 하에 수행하는 것이 바람직하며, 상기 반응을 위한 반응기는 당업계에 알려진 바에 따라 변경이 가능하다. 상기 제조 방법은 후술할 제조예에서 보다 구체화될 수 있다.The reaction is preferably carried out in the presence of a palladium catalyst and a base, and the reactor for the reaction can be changed as known in the art. The manufacturing method may be more specific in Preparation Examples to be described later.

또한, 본 발명은 상기 화학식 1로 표시되는 화합물을 포함하는 유기 발광 소자를 제공한다. 일례로, 본 발명은 제1 전극; 상기 제1 전극과 대향하여 구비된 제2 전극; 및 상기 제1 전극과 상기 제2 전극 사이에 구비된 1층 이상의 유기물 층을 포함하는 유기 발광 소자로서, 상기 유기물층 중 1층 이상은 상기 화학식 1로 표시되는 화합물을 포함하는, 유기 발광 소자를 제공한다. In addition, the present invention provides an organic light emitting device including the compound represented by Formula 1 above. In one example, the present invention provides a first electrode; a second electrode provided to face the first electrode; and one or more organic material layers provided between the first electrode and the second electrode, wherein at least one of the organic material layers includes the compound represented by Chemical Formula 1. do.

본 발명의 유기 발광 소자의 유기물 층은 단층 구조로 이루어질 수도 있으나, 2층 이상의 유기물층이 적층된 다층 구조로 이루어질 수 있다. 예컨대, 본 발명의 유기 발광 소자는 유기물 층으로서 정공주입층, 정공수송층, 발광층, 전자수송층, 전자주입층 등을 포함하는 구조를 가질 수 있다. 그러나 유기 발광 소자의 구조는 이에 한정되지 않고 더 적은 수의 유기층을 포함할 수 있다.The organic material layer of the organic light emitting device of the present invention may have a single-layer structure, or may have a multi-layer structure in which two or more organic material layers are stacked. For example, the organic light emitting device of the present invention may have a structure including a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, an electron injection layer, and the like as organic layers. However, the structure of the organic light emitting device is not limited thereto and may include fewer organic layers.

또한, 상기 유기물 층은 발광층을 포함할 수 있고, 상기 발광층은 상기 화학식 1로 표시되는 화합물을 포함한다. 특히, 본 발명에 따른 화합물은 발광층의 도펀트로 사용할 수 있다. Also, the organic layer may include a light emitting layer, and the light emitting layer includes the compound represented by Chemical Formula 1. In particular, the compound according to the present invention can be used as a dopant of the light emitting layer.

또한, 상기 유기물 층은 전자수송층, 또는 전자주입층을 포함할 수 있고, 상기 전자수송층, 또는 전자주입층은 상기 화학식 1로 표시되는 화합물을 포함한다. In addition, the organic material layer may include an electron transport layer or an electron injection layer, and the electron transport layer or electron injection layer includes the compound represented by Chemical Formula 1.

또한, 상기 전자수송층, 전자주입층, 또는 전자수송 및 전자주입을 동시에 하는 층은 상기 화학식 1로 표시되는 화합물을 포함한다. In addition, the electron transport layer, the electron injection layer, or the layer simultaneously transporting and injecting electrons includes the compound represented by Formula 1.

또한, 상기 유기물 층은 발광층 및 전자수송층을 포함하고, 상기 전자수송층은 상기 화학식 1로 표시되는 화합물을 포함할 수 있다. In addition, the organic material layer may include a light emitting layer and an electron transport layer, and the electron transport layer may include the compound represented by Chemical Formula 1.

또한, 본 발명에 따른 유기 발광 소자는, 기판 상에 양극, 1층 이상의 유기물 층 및 음극이 순차적으로 적층된 구조(normal type)의 유기 발광 소자일 수 있다. 또한, 본 발명에 따른 유기 발광 소자는 기판 상에 음극, 1층 이상의 유기물 층 및 양극이 순차적으로 적층된 역방향 구조(inverted type)의 유기 발광 소자일 수 있다. 예컨대, 본 발명의 일실시예에 따른 유기 발광 소자의 구조는 도 1 및 2에 예시되어 있다.Also, the organic light emitting device according to the present invention may be a normal type organic light emitting device in which an anode, one or more organic material layers, and a cathode are sequentially stacked on a substrate. In addition, the organic light emitting device according to the present invention may be an organic light emitting device of an inverted type in which a cathode, one or more organic material layers, and an anode are sequentially stacked on a substrate. For example, the structure of an organic light emitting device according to an embodiment of the present invention is illustrated in FIGS. 1 and 2 .

도 1은 기판(1), 양극(2), 발광층(3), 음극(4)으로 이루어진 유기 발광 소자의 예를 도시한 것이다. 이와 같은 구조에 있어서, 상기 화학식 1로 표시되는 화합물은 상기 발광층에 포함될 수 있다. 1 shows an example of an organic light emitting device composed of a substrate 1, an anode 2, a light emitting layer 3, and a cathode 4. In this structure, the compound represented by Chemical Formula 1 may be included in the light emitting layer.

도 2는 기판(1), 양극(2), 정공주입층(5), 정공수송층(6), 전자차단층(7), 발광층(3), 정공저지층(8), 전자주입 및 수송층(9) 및 음극(4)로 이루어진 유기 발광 소자의 예를 도시한 것이다. 이와 같은 구조에 있어서, 상기 화학식 1로 표시되는 화합물은 상기 정공주입층, 정공수송층, 발광층 및 전자수송층 중 1층 이상에 포함될 수 있다. 2 shows a substrate 1, an anode 2, a hole injection layer 5, a hole transport layer 6, an electron blocking layer 7, a light emitting layer 3, a hole blocking layer 8, an electron injection and transport layer ( 9) and an example of an organic light emitting element composed of a cathode 4 is shown. In this structure, the compound represented by Formula 1 may be included in at least one layer of the hole injection layer, the hole transport layer, the light emitting layer, and the electron transport layer.

본 발명에 따른 유기 발광 소자는, 상기 유기물 층 중 1층 이상이 상기 화학식 1로 표시되는 화합물을 포함하는 것을 제외하고는 당 기술분야에 알려져 있는 재료와 방법으로 제조될 수 있다. 또한, 상기 유기 발광 소자가 복수개의 유기물층을 포함하는 경우, 상기 유기물층은 동일한 물질 또는 다른 물질로 형성될 수 있다. The organic light emitting device according to the present invention may be manufactured using materials and methods known in the art, except that at least one of the organic layers includes the compound represented by Chemical Formula 1. Also, when the organic light emitting device includes a plurality of organic material layers, the organic material layers may be formed of the same material or different materials.

예컨대, 본 발명에 따른 유기 발광 소자는 기판 상에 제1 전극, 유기물층 및 제2 전극을 순차적으로 적층시켜 제조할 수 있다. 이때, 스퍼터링법(sputtering)이나 전자빔 증발법(e-beam evaporation)과 같은 PVD(physical Vapor Deposition)방법을 이용하여, 기판 상에 금속 또는 전도성을 가지는 금속 산화물 또는 이들의 합금을 증착시켜 양극을 형성하고, 그 위에 정공 주입층, 정공 수송층, 발광층 및 전자 수송층을 포함하는 유기물 층을 형성한 후, 그 위에 음극으로 사용할 수 있는 물질을 증착시켜 제조할 수 있다. 이와 같은 방법 외에도, 기판 상에 음극 물질부터 유기물층, 양극 물질을 차례로 증착시켜 유기 발광 소자를 만들 수 있다. For example, the organic light emitting device according to the present invention may be manufactured by sequentially stacking a first electrode, an organic material layer, and a second electrode on a substrate. At this time, by using a physical vapor deposition (PVD) method such as sputtering or e-beam evaporation, depositing a metal or a metal oxide having conductivity or an alloy thereof on the substrate to form an anode After forming an organic material layer including a hole injection layer, a hole transport layer, a light emitting layer, and an electron transport layer thereon, and depositing a material that can be used as a cathode thereon, it can be prepared. In addition to this method, an organic light emitting device may be manufactured by sequentially depositing a cathode material, an organic material layer, and an anode material on a substrate.

또한, 상기 화학식 1로 표시되는 화합물은 유기 발광 소자의 제조시 진공 증착법 뿐만 아니라 용액 도포법에 의하여 유기물 층으로 형성될 수 있다. 여기서, 용액 도포법이라 함은 스핀 코팅, 딥코팅, 닥터 블레이딩, 잉크젯 프린팅, 스크린 프린팅, 스프레이법, 롤 코팅 등을 의미하지만, 이들만으로 한정되는 것은 아니다.In addition, the compound represented by Chemical Formula 1 may be formed as an organic material layer by a solution coating method as well as a vacuum deposition method when manufacturing an organic light emitting device. Here, the solution coating method means spin coating, dip coating, doctor blading, inkjet printing, screen printing, spraying, roll coating, etc., but is not limited to these.

이와 같은 방법 외에도, 기판 상에 음극 물질로부터 유기물층, 양극 물질을 차례로 증착시켜 유기 발광 소자를 제조할 수 있다(WO 2003/012890). 다만, 제조 방법이 이에 한정되는 것은 아니다. In addition to this method, an organic light emitting device may be manufactured by sequentially depositing an organic material layer and an anode material on a substrate from a cathode material (WO 2003/012890). However, the manufacturing method is not limited thereto.

일례로, 상기 제1 전극은 양극이고, 상기 제2 전극은 음극이거나, 또는 상기 제1 전극은 음극이고, 상기 제2 전극은 양극이다.In one example, the first electrode is an anode and the second electrode is a cathode, or the first electrode is a cathode and the second electrode is an anode.

상기 양극 물질로는 통상 유기물 층으로 정공 주입이 원활할 수 있도록 일함수가 큰 물질이 바람직하다. 상기 양극 물질의 구체적인 예로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연 산화물, 인듐 산화물, 인듐주석 산화물(ITO), 인듐아연 산화물(IZO)과 같은 금속 산화물; ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합; 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDOT), 폴리피롤 및 폴리아닐린과 같은 전도성 고분자 등이 있으나, 이들에만 한정되는 것은 아니다. As the anode material, a material having a high work function is generally preferred so that holes can be smoothly injected into the organic layer. Specific examples of the cathode material include metals such as vanadium, chromium, copper, zinc, and gold or alloys thereof; metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); combinations of metals and oxides such as ZnO:Al or SnO 2 :Sb; Conductive polymers such as poly(3-methylthiophene), poly[3,4-(ethylene-1,2-dioxy)thiophene] (PEDOT), polypyrrole, and polyaniline, but are not limited thereto.

상기 음극 물질로는 통상 유기물층으로 전자 주입이 용이하도록 일함수가 작은 물질인 것이 바람직하다. 상기 음극 물질의 구체적인 예로는 마그네슘, 칼슘, 나트륨, 칼륨, 티타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석 및 납과 같은 금속 또는 이들의 합금; LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등이 있으나, 이들에만 한정되는 것은 아니다. The cathode material is preferably a material having a small work function so as to easily inject electrons into the organic material layer. Specific examples of the anode material include metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, and lead, or alloys thereof; There are multi-layered materials such as LiF/Al or LiO 2 /Al, but are not limited thereto.

상기 정공주입층은 전극으로부터 정공을 주입하는 층으로, 정공 주입 물질로는 정공을 수송하는 능력을 가져 양극에서의 정공 주입효과, 발광층 또는 발광재료에 대하여 우수한 정공 주입 효과를 갖고, 발광층에서 생성된 여기자의 전자주입층 또는 전자주입재료에의 이동을 방지하며, 또한, 박막 형성 능력이 우수한 화합물이 바람직하다. 정공 주입 물질의 HOMO(highest occupied molecular orbital)가 양극 물질의 일함수와 주변 유기물 층의 HOMO 사이인 것이 바람직하다. 정공 주입 물질의 구체적인 예로는 금속 포피린(porphyrin), 올리고티오펜, 아릴아민 계열의 유기물, 헥사니트릴헥사아자트리페닐렌 계열의 유기물, 퀴나크리돈(quinacridone)계열의 유기물, 페릴렌(perylene) 계열의 유기물, 안트라퀴논 및 폴리아닐린과 폴리티오펜 계열의 전도성 고분자 등이 있으나, 이들에만 한정되는 것은 아니다. The hole injection layer is a layer for injecting holes from the electrode, and the hole injection material has the ability to transport holes and has a hole injection effect at the anode, an excellent hole injection effect for the light emitting layer or the light emitting material, and generated in the light emitting layer A compound that prevents migration of excitons to the electron injecting layer or electron injecting material and has excellent thin film formation ability is preferred. It is preferable that the highest occupied molecular orbital (HOMO) of the hole injection material is between the work function of the anode material and the HOMO of the surrounding organic layer. Specific examples of the hole injection material include metal porphyrins, oligothiophenes, arylamine-based organic materials, hexanitrilehexaazatriphenylene-based organic materials, quinacridone-based organic materials, and perylene-based organic materials. of organic materials, anthraquinone, polyaniline, and polythiophene-based conductive polymers, but are not limited thereto.

상기 정공수송층은 정공주입층으로부터 정공을 수취하여 발광층까지 정공을 수송하는 층으로, 정공 수송 물질로 양극이나 정공 주입층으로부터 정공을 수송받아 발광층으로 옮겨줄 수 있는 물질로 정공에 대한 이동성이 큰 물질이 적합하다. 구체적인 예로는 아릴아민 계열의 유기물, 전도성 고분자, 및 공액 부분과 비공액 부분이 함께 있는 블록 공중합체 등이 있으나, 이들에만 한정되는 것은 아니다. The hole transport layer is a layer that receives holes from the hole injection layer and transports the holes to the light emitting layer. As a hole transport material, a material capable of receiving holes from the anode or the hole injection layer and transferring them to the light emitting layer is a material having high hole mobility. this is suitable Specific examples include, but are not limited to, arylamine-based organic materials, conductive polymers, and block copolymers having both conjugated and non-conjugated parts.

상기 발광 물질로는 정공 수송층과 전자 수송층으로부터 정공과 전자를 각각 수송받아 결합시킴으로써 가시광선 영역의 빛을 낼 수 있는 물질로서, 형광이나 인광에 대한 양자 효율이 좋은 물질이 바람직하다. 구체적인 예로 8-히드록시-퀴놀린 알루미늄 착물(Alq3); 카르바졸 계열 화합물; 이량체화 스티릴(dimerized styryl) 화합물; BAlq; 10-히드록시벤조 퀴놀린-금속 화합물; 벤족사졸, 벤즈티아졸 및 벤즈이미다졸 계열의 화합물; 폴리(p-페닐렌비닐렌)(PPV) 계열의 고분자; 스피로(spiro) 화합물; 폴리플루오렌, 루브렌 등이 있으나, 이들에만 한정되는 것은 아니다. The light emitting material is a material capable of emitting light in the visible ray region by receiving and combining holes and electrons from the hole transport layer and the electron transport layer, respectively, and a material having good quantum efficiency for fluorescence or phosphorescence is preferable. Specific examples include 8-hydroxy-quinoline aluminum complex (Alq 3 ); carbazole-based compounds; dimerized styryl compounds; BAlq; 10-hydroxybenzoquinoline-metal compounds; compounds of the benzoxazole, benzthiazole and benzimidazole series; poly(p-phenylenevinylene) (PPV)-based polymers; spiro compounds; Polyfluorene, rubrene, etc., but are not limited thereto.

상기 발광층은 호스트 재료 및 도펀트 재료를 포함할 수 있다. 호스트 재료는 축합 방향족환 유도체 또는 헤테로환 함유 화합물 등이 있다. 구체적으로 축합 방향족환 유도체로는 안트라센 유도체, 피렌 유도체, 나프탈렌 유도체, 펜타센 유도체, 페난트렌 화합물, 플루오란텐 화합물 등이 있고, 헤테로환 함유 화합물로는 카바졸 유도체, 디벤조퓨란 유도체, 래더형 퓨란 화합물, 피리미딘 유도체 등이 있으나, 이에 한정되지 않는다. The light emitting layer may include a host material and a dopant material. The host material includes a condensed aromatic ring derivative or a compound containing a hetero ring. Specifically, condensed aromatic ring derivatives include anthracene derivatives, pyrene derivatives, naphthalene derivatives, pentacene derivatives, phenanthrene compounds, fluoranthene compounds, etc., and heterocyclic-containing compounds include carbazole derivatives, dibenzofuran derivatives, ladder type furan compounds, pyrimidine derivatives, etc., but are not limited thereto.

도펀트 재료로는 방향족 아민 유도체, 스트릴아민 화합물, 붕소 착체, 플루오란텐 화합물, 금속 착체 등이 있다. 구체적으로 방향족 아민 유도체로는 치환 또는 비치환된 아릴아미노기를 갖는 축합 방향족환 유도체로서, 아릴아미노기를 갖는 피렌, 안트라센, 크리센, 페리플란텐 등이 있으며, 스티릴아민 화합물로는 치환 또는 비치환된 아릴아민에 적어도 1개의 아릴비닐기가 치환되어 있는 화합물로, 아릴기, 실릴기, 알킬기, 사이클로알킬기 및 아릴아미노기로 이루어진 군에서 1 또는 2 이상 선택되는 치환기가 치환 또는 비치환된다. 구체적으로 스티릴아민, 스티릴디아민, 스티릴트리아민, 스티릴테트라아민 등이 있으나, 이에 한정되지 않는다. 또한, 금속 착체로는 이리듐 착체, 백금 착체 등이 있으나, 이에 한정되지 않는다.Dopant materials include aromatic amine derivatives, strylamine compounds, boron complexes, fluoranthene compounds, metal complexes, and the like. Specifically, aromatic amine derivatives are condensed aromatic ring derivatives having a substituted or unsubstituted arylamino group, such as pyrene, anthracene, chrysene, periplanthene, etc. having an arylamino group, and styrylamine compounds include substituted or unsubstituted arylamine is substituted with at least one arylvinyl group, wherein one or two or more substituents selected from the group consisting of an aryl group, a silyl group, an alkyl group, a cycloalkyl group, and an arylamino group are substituted or unsubstituted. Specifically, there are styrylamine, styryldiamine, styryltriamine, styryltetraamine, etc., but is not limited thereto. In addition, metal complexes include, but are not limited to, iridium complexes and platinum complexes.

상기 전자수송층은 전자주입층으로부터 전자를 수취하여 발광층까지 전자를 수송하는 층으로 전자 수송 물질로는 음극으로부터 전자를 잘 주입 받아 발광층으로 옮겨줄 수 있는 물질로서, 전자에 대한 이동성이 큰 물질이 적합하다. 구체적인 예로는 8-히드록시퀴놀린의 Al 착물; Alq3을 포함한 착물; 유기 라디칼 화합물; 히드록시플라본-금속 착물 등이 있으나, 이들에만 한정되는 것은 아니다. 전자 수송층은 종래기술에 따라 사용된 바와 같이 임의의 원하는 캐소드 물질과 함께 사용할 수 있다. 특히, 적절한 캐소드 물질의 예는 낮은 일함수를 가지고 알루미늄층 또는 실버층이 뒤따르는 통상적인 물질이다. 구체적으로 세슘, 바륨, 칼슘, 이테르븀 및 사마륨이고, 각 경우 알루미늄 층 또는 실버층이 뒤따른다.The electron transport layer is a layer that receives electrons from the electron injection layer and transports electrons to the light emitting layer. As the electron transport material, a material capable of receiving electrons from the cathode and transferring them to the light emitting layer is suitable. do. Specific examples include Al complexes of 8-hydroxyquinoline; complexes including Alq 3 ; organic radical compounds; hydroxyflavone-metal complexes and the like, but are not limited thereto. The electron transport layer can be used with any desired cathode material as used according to the prior art. In particular, examples of suitable cathode materials are conventional materials having a low work function followed by a layer of aluminum or silver. Specifically cesium, barium, calcium, ytterbium and samarium, followed in each case by a layer of aluminum or silver.

상기 전자주입층은 전극으로부터 전자를 주입하는 층으로, 전자를 수송하는 능력을 갖고, 음극으로부터의 전자 주입 효과, 발광층 또는 발광 재료에 대하여 우수한 전자주입 효과를 가지며, 발광층에서 생성된 여기자의 정공주입층에의 이동을 방지하고, 또한, 박막형성능력이 우수한 화합물이 바람직하다. 구체적으로는 플루오레논, 안트라퀴노다이메탄, 다이페노퀴논, 티오피란 다이옥사이드, 옥사졸, 옥사다이아졸, 트리아졸, 이미다졸, 페릴렌테트라카복실산, 프레오레닐리덴 메탄, 안트론 등과 그들의 유도체, 금속 착체 화합물 및 질소 함유 5원환 유도체 등이 있으나, 이에 한정되지 않는다. The electron injection layer is a layer for injecting electrons from an electrode, has the ability to transport electrons, has an excellent electron injection effect from a cathode, an excellent electron injection effect for a light emitting layer or a light emitting material, and injects holes of excitons generated in the light emitting layer. A compound that prevents migration to a layer and has excellent thin film forming ability is preferred. Specifically, fluorenone, anthraquinodimethane, diphenoquinone, thiopyran dioxide, oxazole, oxadiazole, triazole, imidazole, perylenetetracarboxylic acid, preonylidene methane, anthrone, etc. and their derivatives, metals complex compounds and nitrogen-containing 5-membered ring derivatives, but are not limited thereto.

상기 금속 착체 화합물로서는 8-하이드록시퀴놀리나토 리튬, 비스(8-하이드록시퀴놀리나토)아연, 비스(8-하이드록시퀴놀리나토)구리, 비스(8-하이드록시퀴놀리나토)망간, 트리스(8-하이드록시퀴놀리나토)알루미늄, 트리스(2-메틸-8-하이드록시퀴놀리나토)알루미늄, 트리스(8-하이드록시퀴놀리나토)갈륨, 비스(10-하이드록시벤조[h]퀴놀리나토)베릴륨, 비스(10-하이드록시벤조[h]퀴놀리나토)아연, 비스(2-메틸-8-퀴놀리나토)클로로갈륨, 비스(2-메틸-8-퀴놀리나토)(o-크레졸라토)갈륨, 비스(2-메틸-8-퀴놀리나토)(1-나프톨라토)알루미늄, 비스(2-메틸-8-퀴놀리나토)(2-나프톨라토)갈륨 등이 있으나, 이에 한정되지 않는다.Examples of the metal complex compound include 8-hydroxyquinolinato lithium, bis(8-hydroxyquinolinato)zinc, bis(8-hydroxyquinolinato)copper, bis(8-hydroxyquinolinato)manganese, Tris(8-hydroxyquinolinato) aluminum, tris(2-methyl-8-hydroxyquinolinato) aluminum, tris(8-hydroxyquinolinato) gallium, bis(10-hydroxybenzo[h] Quinolinato) beryllium, bis(10-hydroxybenzo[h]quinolinato)zinc, bis(2-methyl-8-quinolinato)chlorogallium, bis(2-methyl-8-quinolinato)( There are o-cresolato) gallium, bis(2-methyl-8-quinolinato)(1-naphtolato)aluminum, and bis(2-methyl-8-quinolinato)(2-naphtolato)gallium. Not limited to this.

본 발명에 따른 유기 발광 소자는 사용되는 재료에 따라 전면 발광형, 후면 발광형 또는 양면 발광형일 수 있다.The organic light emitting device according to the present invention may be a top emission type, a bottom emission type, or a double side emission type depending on the material used.

또한, 상기 화학식 1로 표시되는 화합물은 유기 발광 소자 외에도 유기 태양 전지 또는 유기 트랜지스터에 포함될 수 있다.In addition, the compound represented by Chemical Formula 1 may be included in an organic solar cell or an organic transistor in addition to an organic light emitting device.

[실시예][Example]

제조예 1Preparation Example 1

Figure pat00022
Figure pat00022

5-bromo-2-chloropyridin-4-amine (15g, 72.3mmol)와 (2-methoxynaphthalen-1-yl)boronic acid (15.3g, 75.9mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(30g, 216.9mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.4g, 0.7mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-1-1_P1을 14g 제조하였다. (수율 68%, MS: [M+H]+= 285)5-bromo-2-chloropyridin-4-amine (15g, 72.3mmol) and (2-methoxynaphthalen-1-yl)boronic acid (15.3g, 75.9mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (30g, 216.9mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.4g, 0.7mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14 g of compound A-1-1_P1. (Yield 68%, MS: [M+H] + = 285)

화합물 A-1-1_P1 (15g, 52.7mmol)와 HBF4 (9.3g, 105.4mmol)를 Acetonitrile 150ml에 넣고 교반하였다. 이 후 NaNO2(14.6g, 105.4mmol)를 물 30ml에 녹여 0oC에서 천천히 넣어주었다. 8시간 반응 후 상온으로 승온 후, 물 300ml를 넣어 희석하였다. 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-1-1_P2를 6.9g 제조하였다. (수율 52%, MS: [M+H]+= 254)Compound A-1-1_P1 (15g, 52.7mmol) and HBF 4 (9.3g, 105.4mmol) were added to 150ml of Acetonitrile and stirred. After that, NaNO 2 (14.6g, 105.4mmol) was dissolved in 30ml of water and added slowly at 0 o C. After reacting for 8 hours, the temperature was raised to room temperature, and diluted with 300 ml of water. After dissolving in chloroform and washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 6.9 g of compound A-1-1_P2. (Yield 52%, MS: [M+H] + = 254)

화합물 A-1-1_P2 (15g, 59.1mmol)와 bis(pinacolato)diboron (16.5g, 65mmol)를 1,4-dioxane 300ml에 환류시키며 교반하였다. 이 후 potassium acetate (8.7g, 88.7mmol)를 투입하고 충분히 교반한 후 bis(dibenzylideneacetone)palladium(0) (1g, 1.8mmol) 및 tricyclohexylphosphine (1g, 3.5mmol)을 투입하였다. 10시간 반응하고 상온으로 식히고 클로로포름과 물을 이용하여 유기층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-1-1을 12.9g 제조하였다. (수율 63%, MS: [M+H]+= 346)Compound A-1-1_P2 (15g, 59.1mmol) and bis(pinacolato)diboron (16.5g, 65mmol) were stirred while refluxing in 300ml of 1,4-dioxane. After that, potassium acetate (8.7g, 88.7mmol) was added, and after sufficient stirring, bis(dibenzylideneacetone)palladium(0) (1g, 1.8mmol) and tricyclohexylphosphine (1g, 3.5mmol) were added. After reacting for 10 hours, cooling to room temperature and separating the organic layer using chloroform and water, the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 12.9 g of Compound A-1-1. (Yield 63%, MS: [M+H] + = 346)

제조예 2Preparation Example 2

Figure pat00023
Figure pat00023

3-bromopyridin-4-amine (15g, 86.7mmol)와 (6-chloro-2-methoxynaphthalen-1-yl)boronic acid (21.3g, 91mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(35.9g, 260.1mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.4g, 0.9mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-1-6_P1을 17.5g 제조하였다. (수율 71%, MS: [M+H]+= 285)3-bromopyridin-4-amine (15g, 86.7mmol) and (6-chloro-2-methoxynaphthalen-1-yl)boronic acid (21.3g, 91mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (35.9g, 260.1mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.4g, 0.9mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 17.5 g of compound A-1-6_P1. (Yield 71%, MS: [M+H] + = 285)

화합물 A-1-6_P1 (15g, 52.7mmol)와 HBF4 (9.3g, 105.4mmol)를 Acetonitrile 150ml에 넣고 교반하였다. 이 후 NaNO2(14.6g, 105.4mmol)를 물 30ml에 녹여 0oC에서 천천히 넣어주었다. 10시간 반응 후 상온으로 승온 후, 물 300ml를 넣어 희석하였다. 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-1-6_P2를 7.3g 제조하였다. (수율 55%, MS: [M+H]+= 254)Compound A-1-6_P1 (15g, 52.7mmol) and HBF 4 (9.3g, 105.4mmol) were added to 150ml of Acetonitrile and stirred. After that, NaNO 2 (14.6g, 105.4mmol) was dissolved in 30ml of water and added slowly at 0 o C. After reacting for 10 hours, the temperature was raised to room temperature, and diluted with 300 ml of water. After dissolving in chloroform and washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 7.3 g of compound A-1-6_P2. (Yield 55%, MS: [M+H] + = 254)

화합물 A-1-6_P2 (15g, 59.1mmol)와 bis(pinacolato)diboron (16.5g, 65mmol)를 1,4-dioxane 300ml에 환류시키며 교반하였다. 이 후 potassium acetate (8.7g, 88.7mmol)를 투입하고 충분히 교반한 후 bis(dibenzylideneacetone)palladium(0) (1g, 1.8mmol) 및 tricyclohexylphosphine (1g, 3.5mmol)을 투입하였다. 8시간 반응하고 상온으로 식히고 클로로포름과 물을 이용하여 유기층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-1-6을 14.5g 제조하였다. (수율 71%, MS: [M+H]+= 346)Compound A-1-6_P2 (15g, 59.1mmol) and bis(pinacolato)diboron (16.5g, 65mmol) were stirred while refluxing in 300ml of 1,4-dioxane. After that, potassium acetate (8.7g, 88.7mmol) was added, and after sufficient stirring, bis(dibenzylideneacetone)palladium(0) (1g, 1.8mmol) and tricyclohexylphosphine (1g, 3.5mmol) were added. After reacting for 8 hours, cooling to room temperature and separating the organic layer using chloroform and water, the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.5 g of Compound A-1-6. (Yield 71%, MS: [M+H] + = 346)

제조예 3Preparation Example 3

Figure pat00024
Figure pat00024

4-bromopyridin-3-amine (15g, 86.7mmol)와 (7-chloro-2-methoxynaphthalen-1-yl)boronic acid (21.3g, 91mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(35.9g, 260.1mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.4g, 0.9mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-2-7_P1을 16.3g 제조하였다. (수율 66%, MS: [M+H]+= 285)4-bromopyridin-3-amine (15g, 86.7mmol) and (7-chloro-2-methoxynaphthalen-1-yl)boronic acid (21.3g, 91mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (35.9g, 260.1mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.4g, 0.9mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 16.3 g of compound A-2-7_P1. (Yield 66%, MS: [M+H] + = 285)

화합물 A-2-7_P1 (15g, 52.7mmol)와 HBF4 (9.3g, 105.4mmol)를 Acetonitrile 150ml에 넣고 교반하였다. 이 후 NaNO2(14.6g, 105.4mmol)를 물 30ml에 녹여 0oC에서 천천히 넣어주었다. 9시간 반응 후 상온으로 승온 후, 물 300ml를 넣어 희석하였다. 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-2-7_P2를 7.3g 제조하였다. (수율 55%, MS: [M+H]+= 254)Compound A-2-7_P1 (15g, 52.7mmol) and HBF 4 (9.3g, 105.4mmol) were added to 150ml of Acetonitrile and stirred. After that, NaNO 2 (14.6g, 105.4mmol) was dissolved in 30ml of water and added slowly at 0 o C. After reacting for 9 hours, the temperature was raised to room temperature, and diluted with 300 ml of water. After dissolving in chloroform and washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 7.3 g of compound A-2-7_P2. (Yield 55%, MS: [M+H] + = 254)

화합물 A-2-7_P2 (15g, 59.1mmol)와 bis(pinacolato)diboron (16.5g, 65mmol)를 1,4-dioxane 300ml에 환류시키며 교반하였다. 이 후 potassium acetate (8.7g, 88.7mmol)를 투입하고 충분히 교반한 후 bis(dibenzylideneacetone)palladium(0) (1g, 1.8mmol) 및 tricyclohexylphosphine (1g, 3.5mmol)을 투입하였다. 9시간 반응하고 상온으로 식히고 클로로포름과 물을 이용하여 유기층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-2-7을 12.2g 제조하였다. (수율 60%, MS: [M+H]+= 346)Compound A-2-7_P2 (15g, 59.1mmol) and bis(pinacolato)diboron (16.5g, 65mmol) were stirred while refluxing in 300ml of 1,4-dioxane. After that, potassium acetate (8.7g, 88.7mmol) was added, and after sufficient stirring, bis(dibenzylideneacetone)palladium(0) (1g, 1.8mmol) and tricyclohexylphosphine (1g, 3.5mmol) were added. After reacting for 9 hours, cooling to room temperature and separating the organic layer using chloroform and water, the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 12.2 g of compound A-2-7. (Yield 60%, MS: [M+H] + = 346)

제조예 4Production Example 4

Figure pat00025
Figure pat00025

3-bromo-5-chloropyridin-2-amine (15g, 73.7mmol)와 (2-methoxynaphthalen-1-yl)boronic acid (15.6g, 77.4mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(30.6g, 221.2mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.4g, 0.7mmol)을 투입하였다. 3시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-3-1_P1을 15.5g 제조하였다. (수율 74%, MS: [M+H]+= 285)3-bromo-5-chloropyridin-2-amine (15g, 73.7mmol) and (2-methoxynaphthalen-1-yl)boronic acid (15.6g, 77.4mmol) were added to 300ml of THF and stirred and refluxed. After that, potassium carbonate (30.6g, 221.2mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.4g, 0.7mmol) was added. After reacting for 3 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 15.5 g of compound A-3-1_P1. (Yield 74%, MS: [M+H] + = 285)

화합물 A-3-1_P1 (15g, 52.7mmol)와 HBF4 (9.3g, 105.4mmol)를 Acetonitrile 150ml에 넣고 교반하였다. 이 후 NaNO2(14.6g, 105.4mmol)를 물 30ml에 녹여 0oC에서 천천히 넣어주었다. 8시간 반응 후 상온으로 승온 후, 물 300ml를 넣어 희석하였다. 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-3-1_P2를 7.9g 제조하였다. (수율 59%, MS: [M+H]+= 254)Compound A-3-1_P1 (15g, 52.7mmol) and HBF 4 (9.3g, 105.4mmol) were added to 150ml of Acetonitrile and stirred. After that, NaNO 2 (14.6g, 105.4mmol) was dissolved in 30ml of water and added slowly at 0 o C. After reacting for 8 hours, the temperature was raised to room temperature, and diluted with 300 ml of water. After dissolving in chloroform and washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 7.9 g of compound A-3-1_P2. (Yield 59%, MS: [M+H] + = 254)

화합물 A-3-1_P2 (15g, 59.1mmol)와 bis(pinacolato)diboron (16.5g, 65mmol)를 1,4-dioxane 300ml에 환류시키며 교반하였다. 이 후 potassium acetate (8.7g, 88.7mmol)를 투입하고 충분히 교반한 후 bis(dibenzylideneacetone)palladium(0) (1g, 1.8mmol) 및 tricyclohexylphosphine (1g, 3.5mmol)을 투입하였다. 6시간 반응하고 상온으로 식히고 클로로포름과 물을 이용하여 유기층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-3-1을 13.3g 제조하였다. (수율 65%, MS: [M+H]+= 346)Compound A-3-1_P2 (15g, 59.1mmol) and bis(pinacolato)diboron (16.5g, 65mmol) were stirred while refluxing in 300ml of 1,4-dioxane. After that, potassium acetate (8.7g, 88.7mmol) was added, and after sufficient stirring, bis(dibenzylideneacetone)palladium(0) (1g, 1.8mmol) and tricyclohexylphosphine (1g, 3.5mmol) were added. After reacting for 6 hours, cooling to room temperature and separating the organic layer using chloroform and water, the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13.3 g of Compound A-3-1. (Yield 65%, MS: [M+H] + = 346)

제조예 5Preparation Example 5

Figure pat00026
Figure pat00026

3-bromopyridin-2-amine (15g, 86.7mmol)와 (5-chloro-2-methoxynaphthalen-1-yl)boronic acid (21.5g, 91mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(35.9g, 260.1mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.4g, 0.9mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-3-5_P1을 17.7g 제조하였다. (수율 72%, MS: [M+H]+= 285)3-bromopyridin-2-amine (15g, 86.7mmol) and (5-chloro-2-methoxynaphthalen-1-yl)boronic acid (21.5g, 91mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (35.9g, 260.1mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.4g, 0.9mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 17.7 g of compound A-3-5_P1. (Yield 72%, MS: [M+H] + = 285)

화합물 A-3-5_P1 (15g, 52.7mmol)와 HBF4 (9.3g, 105.4mmol)를 Acetonitrile 150ml에 넣고 교반하였다. 이 후 NaNO2(14.6g, 105.4mmol)를 물 30ml에 녹여 0oC에서 천천히 넣어주었다. 9시간 반응 후 상온으로 승온 후, 물 300ml를 넣어 희석하였다. 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-3-5_P2를 7.1g 제조하였다. (수율 53%, MS: [M+H]+= 254)Compound A-3-5_P1 (15g, 52.7mmol) and HBF 4 (9.3g, 105.4mmol) were added to 150ml of Acetonitrile and stirred. After that, NaNO 2 (14.6g, 105.4mmol) was dissolved in 30ml of water and added slowly at 0 o C. After reacting for 9 hours, the temperature was raised to room temperature, and diluted with 300 ml of water. After dissolving in chloroform and washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 7.1 g of compound A-3-5_P2. (Yield 53%, MS: [M+H] + = 254)

화합물 A-3-5_P2 (15g, 59.1mmol)와 bis(pinacolato)diboron (16.5g, 65mmol)를 1,4-dioxane 300ml에 환류시키며 교반하였다. 이 후 potassium acetate (8.7g, 88.7mmol)를 투입하고 충분히 교반한 후 bis(dibenzylideneacetone)palladium(0) (1g, 1.8mmol) 및 tricyclohexylphosphine (1g, 3.5mmol)을 투입하였다. 7시간 반응하고 상온으로 식히고 클로로포름과 물을 이용하여 유기층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-3-5를 15.3g 제조하였다. (수율 75%, MS: [M+H]+= 346)Compound A-3-5_P2 (15g, 59.1mmol) and bis(pinacolato)diboron (16.5g, 65mmol) were stirred while refluxing in 300ml of 1,4-dioxane. After that, potassium acetate (8.7g, 88.7mmol) was added, and after sufficient stirring, bis(dibenzylideneacetone)palladium(0) (1g, 1.8mmol) and tricyclohexylphosphine (1g, 3.5mmol) were added. After reacting for 7 hours, cooling to room temperature and separating the organic layer using chloroform and water, the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 15.3 g of compound A-3-5. (Yield 75%, MS: [M+H] + = 346)

제조예 6Preparation Example 6

Figure pat00027
Figure pat00027

2-bromo-4-chloropyridin-3-amine (15g, 73.7mmol)와 (2-methoxynaphthalen-1-yl)boronic acid (15.6g, 77.4mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(30.6g, 221.2mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.4g, 0.7mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-4-3_P1을 14.5g 제조하였다. (수율 69%, MS: [M+H]+= 285)2-bromo-4-chloropyridin-3-amine (15g, 73.7mmol) and (2-methoxynaphthalen-1-yl)boronic acid (15.6g, 77.4mmol) were added to 300ml of THF and stirred and refluxed. After that, potassium carbonate (30.6g, 221.2mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.4g, 0.7mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.5 g of compound A-4-3_P1. (Yield 69%, MS: [M+H] + = 285)

화합물 A-4-3_P1 (15g, 52.7mmol)와 HBF4 (9.3g, 105.4mmol)를 Acetonitrile 150ml에 넣고 교반하였다. 이 후 NaNO2(14.6g, 105.4mmol)를 물 30ml에 녹여 0oC에서 천천히 넣어주었다. 8시간 반응 후 상온으로 승온 후, 물 300ml를 넣어 희석하였다. 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-4-3_P2를 9.2g 제조하였다. (수율 69%, MS: [M+H]+= 254)Compound A-4-3_P1 (15g, 52.7mmol) and HBF 4 (9.3g, 105.4mmol) were added to 150ml of Acetonitrile and stirred. After that, NaNO 2 (14.6g, 105.4mmol) was dissolved in 30ml of water and added slowly at 0 o C. After reacting for 8 hours, the temperature was raised to room temperature, and diluted with 300 ml of water. After dissolving in chloroform and washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 9.2 g of compound A-4-3_P2. (Yield 69%, MS: [M+H] + = 254)

화합물 A-4-3_P2 (15g, 59.1mmol)와 bis(pinacolato)diboron (16.5g, 65mmol)를 1,4-dioxane 300ml에 환류시키며 교반하였다. 이 후 potassium acetate (8.7g, 88.7mmol)를 투입하고 충분히 교반한 후 bis(dibenzylideneacetone)palladium(0) (1g, 1.8mmol) 및 tricyclohexylphosphine (1g, 3.5mmol)을 투입하였다. 5시간 반응하고 상온으로 식히고 클로로포름과 물을 이용하여 유기층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-4-3을 13.1g 제조하였다. (수율 64%, MS: [M+H]+= 346)Compound A-4-3_P2 (15g, 59.1mmol) and bis(pinacolato)diboron (16.5g, 65mmol) were stirred while refluxing in 300ml of 1,4-dioxane. After that, potassium acetate (8.7g, 88.7mmol) was added, and after sufficient stirring, bis(dibenzylideneacetone)palladium(0) (1g, 1.8mmol) and tricyclohexylphosphine (1g, 3.5mmol) were added. After reacting for 5 hours, cooling to room temperature and separating the organic layer using chloroform and water, the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13.1 g of compound A-4-3. (Yield 64%, MS: [M+H] + = 346)

제조예 7Preparation Example 7

Figure pat00028
Figure pat00028

2-bromo-6-chloroaniline (15g, 72.6mmol)와 (3-methoxyisoquinolin-4-yl)boronic acid (15.5g, 76.3mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(30.1g, 217.9mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.4g, 0.7mmol)을 투입하였다. 3시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-5-3_P1을 13.8g 제조하였다. (수율 67%, MS: [M+H]+= 285)2-bromo-6-chloroaniline (15g, 72.6mmol) and (3-methoxyisoquinolin-4-yl)boronic acid (15.5g, 76.3mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (30.1g, 217.9mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.4g, 0.7mmol) was added. After reacting for 3 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13.8 g of compound A-5-3_P1. (Yield 67%, MS: [M+H] + = 285)

화합물 A-5-3_P1 (15g, 52.7mmol)와 HBF4 (9.3g, 105.4mmol)를 Acetonitrile 150ml에 넣고 교반하였다. 이 후 NaNO2(14.6g, 105.4mmol)를 물 30ml에 녹여 0oC에서 천천히 넣어주었다. 10시간 반응 후 상온으로 승온 후, 물 300ml를 넣어 희석하였다. 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-5-3_P2를 8.3g 제조하였다. (수율 62%, MS: [M+H]+= 254)Compound A-5-3_P1 (15g, 52.7mmol) and HBF 4 (9.3g, 105.4mmol) were added to 150ml of Acetonitrile and stirred. After that, NaNO 2 (14.6g, 105.4mmol) was dissolved in 30ml of water and added slowly at 0 o C. After reacting for 10 hours, the temperature was raised to room temperature, and diluted with 300 ml of water. After dissolving in chloroform and washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 8.3 g of compound A-5-3_P2. (Yield 62%, MS: [M+H] + = 254)

화합물 A-5-3_P2 (15g, 59.1mmol)와 bis(pinacolato)diboron (16.5g, 65mmol)를 1,4-dioxane 300ml에 환류시키며 교반하였다. 이 후 potassium acetate (8.7g, 88.7mmol)를 투입하고 충분히 교반한 후 bis(dibenzylideneacetone)palladium(0) (1g, 1.8mmol) 및 tricyclohexylphosphine (1g, 3.5mmol)을 투입하였다. 7시간 반응하고 상온으로 식히고 클로로포름과 물을 이용하여 유기층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-5-3을 14.9g 제조하였다. (수율 73%, MS: [M+H]+= 346)Compound A-5-3_P2 (15g, 59.1mmol) and bis(pinacolato)diboron (16.5g, 65mmol) were stirred while refluxing in 300ml of 1,4-dioxane. After that, potassium acetate (8.7g, 88.7mmol) was added, and after sufficient stirring, bis(dibenzylideneacetone)palladium(0) (1g, 1.8mmol) and tricyclohexylphosphine (1g, 3.5mmol) were added. After reacting for 7 hours, cooling to room temperature and separating the organic layer using chloroform and water, the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.9 g of compound A-5-3. (Yield 73%, MS: [M+H] + = 346)

제조예 8Preparation Example 8

Figure pat00029
Figure pat00029

2-bromoaniline (15g, 87.2mmol)와 (7-chloro-3-methoxyquinolin-4-yl)boronic acid (21.7g, 91.5mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(36.2g, 261.6mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.4g, 0.9mmol)을 투입하였다. 3시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-6-6_P1을 18.6g 제조하였다. (수율 75%, MS: [M+H]+= 285)2-bromoaniline (15g, 87.2mmol) and (7-chloro-3-methoxyquinolin-4-yl)boronic acid (21.7g, 91.5mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (36.2g, 261.6mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.4g, 0.9mmol) was added. After reacting for 3 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 18.6 g of compound A-6-6_P1. (Yield 75%, MS: [M+H] + = 285)

화합물 A-6-6_P1 (15g, 52.7mmol)와 HBF4 (9.3g, 105.4mmol)를 Acetonitrile 150ml에 넣고 교반하였다. 이 후 NaNO2(14.6g, 105.4mmol)를 물 30ml에 녹여 0oC에서 천천히 넣어주었다. 8시간 반응 후 상온으로 승온 후, 물 300ml를 넣어 희석하였다. 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-6-6_P2를 7.7g 제조하였다. (수율 58%, MS: [M+H]+= 254)Compound A-6-6_P1 (15g, 52.7mmol) and HBF 4 (9.3g, 105.4mmol) were added to 150ml of Acetonitrile and stirred. After that, NaNO 2 (14.6g, 105.4mmol) was dissolved in 30ml of water and added slowly at 0 o C. After reacting for 8 hours, the temperature was raised to room temperature, and diluted with 300 ml of water. After dissolving in chloroform and washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 7.7 g of compound A-6-6_P2. (Yield 58%, MS: [M+H] + = 254)

화합물 A-6-6_P2 (15g, 59.1mmol)와 bis(pinacolato)diboron (16.5g, 65mmol)를 1,4-dioxane 300ml에 환류시키며 교반하였다. 이 후 potassium acetate (8.7g, 88.7mmol)를 투입하고 충분히 교반한 후 bis(dibenzylideneacetone)palladium(0) (1g, 1.8mmol) 및 tricyclohexylphosphine (1g, 3.5mmol)을 투입하였다. 7시간 반응하고 상온으로 식히고 클로로포름과 물을 이용하여 유기층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-6-6을 15.3g 제조하였다. (수율 75%, MS: [M+H]+= 346)Compound A-6-6_P2 (15g, 59.1mmol) and bis(pinacolato)diboron (16.5g, 65mmol) were stirred while refluxing in 300ml of 1,4-dioxane. After that, potassium acetate (8.7g, 88.7mmol) was added, and after sufficient stirring, bis(dibenzylideneacetone)palladium(0) (1g, 1.8mmol) and tricyclohexylphosphine (1g, 3.5mmol) were added. After reacting for 7 hours, cooling to room temperature and separating the organic layer using chloroform and water, the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 15.3 g of compound A-6-6. (Yield 75%, MS: [M+H] + = 346)

제조예 9Preparation Example 9

Figure pat00030
Figure pat00030

2-bromoaniline (15g, 87.2mmol)와 (7-chloro-6-methoxyquinolin-5-yl)boronic acid (21.7g, 91.5mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(36.2g, 261.6mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.4g, 0.9mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-7-4_P1을 18.1g 제조하였다. (수율 73%, MS: [M+H]+= 285)2-bromoaniline (15g, 87.2mmol) and (7-chloro-6-methoxyquinolin-5-yl)boronic acid (21.7g, 91.5mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (36.2g, 261.6mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.4g, 0.9mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 18.1 g of compound A-7-4_P1. (Yield 73%, MS: [M+H] + = 285)

화합물 A-7-4_P1 (15g, 52.7mmol)와 HBF4 (9.3g, 105.4mmol)를 Acetonitrile 150ml에 넣고 교반하였다. 이 후 NaNO2(14.6g, 105.4mmol)를 물 30ml에 녹여 0oC에서 천천히 넣어주었다. 10시간 반응 후 상온으로 승온 후, 물 300ml를 넣어 희석하였다. 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-7-4_P2를 7.9g 제조하였다. (수율 59%, MS: [M+H]+= 254)Compound A-7-4_P1 (15g, 52.7mmol) and HBF 4 (9.3g, 105.4mmol) were added to 150ml of Acetonitrile and stirred. After that, NaNO 2 (14.6g, 105.4mmol) was dissolved in 30ml of water and added slowly at 0 o C. After reacting for 10 hours, the temperature was raised to room temperature, and diluted with 300 ml of water. After dissolving in chloroform and washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 7.9 g of compound A-7-4_P2. (Yield 59%, MS: [M+H] + = 254)

화합물 A-7-4_P2 (15g, 59.1mmol)와 bis(pinacolato)diboron (16.5g, 65mmol)를 1,4-dioxane 300ml에 환류시키며 교반하였다. 이 후 potassium acetate (8.7g, 88.7mmol)를 투입하고 충분히 교반한 후 bis(dibenzylideneacetone)palladium(0) (1g, 1.8mmol) 및 tricyclohexylphosphine (1g, 3.5mmol)을 투입하였다. 8시간 반응하고 상온으로 식히고 클로로포름과 물을 이용하여 유기층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-7-4를 13.1g 제조하였다. (수율 64%, MS: [M+H]+= 346)Compound A-7-4_P2 (15g, 59.1mmol) and bis(pinacolato)diboron (16.5g, 65mmol) were stirred while refluxing in 300ml of 1,4-dioxane. After that, potassium acetate (8.7g, 88.7mmol) was added, and after sufficient stirring, bis(dibenzylideneacetone)palladium(0) (1g, 1.8mmol) and tricyclohexylphosphine (1g, 3.5mmol) were added. After reacting for 8 hours, cooling to room temperature and separating the organic layer using chloroform and water, the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13.1 g of Compound A-7-4. (Yield 64%, MS: [M+H] + = 346)

제조예 10Preparation Example 10

Figure pat00031
Figure pat00031

2-bromo-5-chloroaniline (15g, 72.6mmol)와 (6-methoxyisoquinolin-5-yl)boronic acid (15.5g, 76.3mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(30.1g, 217.9mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.4g, 0.7mmol)을 투입하였다. 2시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-8-2_P1을 13.6g 제조하였다. (수율 66%, MS: [M+H]+= 285)2-bromo-5-chloroaniline (15g, 72.6mmol) and (6-methoxyisoquinolin-5-yl)boronic acid (15.5g, 76.3mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (30.1g, 217.9mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.4g, 0.7mmol) was added. After reacting for 2 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13.6 g of compound A-8-2_P1. (Yield 66%, MS: [M+H] + = 285)

화합물 A-8-2_P1 (15g, 52.7mmol)와 HBF4 (9.3g, 105.4mmol)를 Acetonitrile 150ml에 넣고 교반하였다. 이 후 NaNO2(14.6g, 105.4mmol)를 물 30ml에 녹여 0oC에서 천천히 넣어주었다. 8시간 반응 후 상온으로 승온 후, 물 300ml를 넣어 희석하였다. 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-8-2_P2를 9.2g 제조하였다. (수율 69%, MS: [M+H]+= 254)Compound A-8-2_P1 (15g, 52.7mmol) and HBF 4 (9.3g, 105.4mmol) were added to 150ml of Acetonitrile and stirred. After that, NaNO 2 (14.6g, 105.4mmol) was dissolved in 30ml of water and added slowly at 0 o C. After reacting for 8 hours, the temperature was raised to room temperature, and diluted with 300 ml of water. After dissolving in chloroform and washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 9.2 g of compound A-8-2_P2. (Yield 69%, MS: [M+H] + = 254)

화합물 A-8-2_P2 (15g, 59.1mmol)와 bis(pinacolato)diboron (16.5g, 65mmol)를 1,4-dioxane 300ml에 환류시키며 교반하였다. 이 후 potassium acetate (8.7g, 88.7mmol)를 투입하고 충분히 교반한 후 bis(dibenzylideneacetone)palladium(0) (1g, 1.8mmol) 및 tricyclohexylphosphine (1g, 3.5mmol)을 투입하였다. 6시간 반응하고 상온으로 식히고 클로로포름과 물을 이용하여 유기층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-8-2를 13.9g 제조하였다. (수율 68%, MS: [M+H]+= 346)Compound A-8-2_P2 (15g, 59.1mmol) and bis(pinacolato)diboron (16.5g, 65mmol) were stirred while refluxing in 300ml of 1,4-dioxane. After that, potassium acetate (8.7g, 88.7mmol) was added, and after sufficient stirring, bis(dibenzylideneacetone)palladium(0) (1g, 1.8mmol) and tricyclohexylphosphine (1g, 3.5mmol) were added. After reacting for 6 hours, cooling to room temperature and separating the organic layer using chloroform and water, the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13.9 g of compound A-8-2. (Yield 68%, MS: [M+H] + = 346)

제조예 11Preparation Example 11

Figure pat00032
Figure pat00032

2-bromo-4-chloroaniline (15g, 72.6mmol)와 (7-methoxyisoquinolin-8-yl)boronic acid (15.5g, 76.3mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(30.1g, 217.9mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.4g, 0.7mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-9-1_P1을 14.2g 제조하였다. (수율 69%, MS: [M+H]+= 285)2-bromo-4-chloroaniline (15g, 72.6mmol) and (7-methoxyisoquinolin-8-yl)boronic acid (15.5g, 76.3mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (30.1g, 217.9mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.4g, 0.7mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.2 g of compound A-9-1_P1. (Yield 69%, MS: [M+H] + = 285)

화합물 A-9-1_P1 (15g, 52.7mmol)와 HBF4 (9.3g, 105.4mmol)를 Acetonitrile 150ml에 넣고 교반하였다. 이 후 NaNO2(14.6g, 105.4mmol)를 물 30ml에 녹여 0oC에서 천천히 넣어주었다. 10시간 반응 후 상온으로 승온 후, 물 300ml를 넣어 희석하였다. 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-9-1_P2를 9.9g 제조하였다. (수율 74%, MS: [M+H]+= 254)Compound A-9-1_P1 (15g, 52.7mmol) and HBF 4 (9.3g, 105.4mmol) were added to 150ml of Acetonitrile and stirred. After that, NaNO 2 (14.6g, 105.4mmol) was dissolved in 30ml of water and added slowly at 0 o C. After reacting for 10 hours, the temperature was raised to room temperature, and diluted with 300 ml of water. After dissolving in chloroform and washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 9.9 g of compound A-9-1_P2. (Yield 74%, MS: [M+H] + = 254)

화합물 A-9-1_P2 (15g, 59.1mmol)와 bis(pinacolato)diboron (16.5g, 65mmol)를 1,4-dioxane 300ml에 환류시키며 교반하였다. 이 후 potassium acetate (8.7g, 88.7mmol)를 투입하고 충분히 교반한 후 bis(dibenzylideneacetone)palladium(0) (1g, 1.8mmol) 및 tricyclohexylphosphine (1g, 3.5mmol)을 투입하였다. 8시간 반응하고 상온으로 식히고 클로로포름과 물을 이용하여 유기층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-9-1을 14.5g 제조하였다. (수율 71%, MS: [M+H]+= 346)Compound A-9-1_P2 (15g, 59.1mmol) and bis(pinacolato)diboron (16.5g, 65mmol) were stirred while refluxing in 300ml of 1,4-dioxane. After that, potassium acetate (8.7g, 88.7mmol) was added, and after sufficient stirring, bis(dibenzylideneacetone)palladium(0) (1g, 1.8mmol) and tricyclohexylphosphine (1g, 3.5mmol) were added. After reacting for 8 hours, cooling to room temperature and separating the organic layer using chloroform and water, the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.5 g of Compound A-9-1. (Yield 71%, MS: [M+H] + = 346)

제조예 12Preparation Example 12

Figure pat00033
Figure pat00033

2-bromoaniline (15g, 87.2mmol)와 (5-chloro-7-methoxyquinolin-8-yl)boronic acid (21.7g, 91.5mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(36.2g, 261.6mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.4g, 0.9mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-10-5_P1을 18.1g 제조하였다. (수율 73%, MS: [M+H]+= 285)2-bromoaniline (15g, 87.2mmol) and (5-chloro-7-methoxyquinolin-8-yl)boronic acid (21.7g, 91.5mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (36.2g, 261.6mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.4g, 0.9mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 18.1 g of compound A-10-5_P1. (Yield 73%, MS: [M+H] + = 285)

화합물 A-10-5_P1 (15g, 52.7mmol)와 HBF4 (9.3g, 105.4mmol)를 Acetonitrile 150ml에 넣고 교반하였다. 이 후 NaNO2(14.6g, 105.4mmol)를 물 30ml에 녹여 0oC에서 천천히 넣어주었다. 8시간 반응 후 상온으로 승온 후, 물 300ml를 넣어 희석하였다. 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-10-5_P2를 8.4g 제조하였다. (수율 63%, MS: [M+H]+= 254)Compound A-10-5_P1 (15g, 52.7mmol) and HBF 4 (9.3g, 105.4mmol) were added to 150ml of Acetonitrile and stirred. After that, NaNO 2 (14.6g, 105.4mmol) was dissolved in 30ml of water and added slowly at 0 o C. After reacting for 8 hours, the temperature was raised to room temperature, and diluted with 300 ml of water. After dissolving in chloroform and washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 8.4 g of compound A-10-5_P2. (Yield 63%, MS: [M+H] + = 254)

화합물 A-10-5_P2 (15g, 59.1mmol)와 bis(pinacolato)diboron (16.5g, 65mmol)를 1,4-dioxane 300ml에 환류시키며 교반하였다. 이 후 potassium acetate (8.7g, 88.7mmol)를 투입하고 충분히 교반한 후 bis(dibenzylideneacetone)palladium(0) (1g, 1.8mmol) 및 tricyclohexylphosphine (1g, 3.5mmol)을 투입하였다. 9시간 반응하고 상온으로 식히고 클로로포름과 물을 이용하여 유기층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-10-5를 14.1g 제조하였다. (수율 69%, MS: [M+H]+= 346)Compound A-10-5_P2 (15g, 59.1mmol) and bis(pinacolato)diboron (16.5g, 65mmol) were stirred while refluxing in 300ml of 1,4-dioxane. After that, potassium acetate (8.7g, 88.7mmol) was added, and after sufficient stirring, bis(dibenzylideneacetone)palladium(0) (1g, 1.8mmol) and tricyclohexylphosphine (1g, 3.5mmol) were added. After reacting for 9 hours, cooling to room temperature and separating the organic layer using chloroform and water, the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.1 g of compound A-10-5. (Yield 69%, MS: [M+H] + = 346)

합성예 1Synthesis Example 1

Figure pat00034
Figure pat00034

Trz1 (15g, 41.9mmol)와 화합물 A-3-2 (15.2g, 44mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(17.4g, 125.8mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 3시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 1을 16.3g 제조하였다. (수율 72%, MS: [M+H]+= 541)Trz1 (15g, 41.9mmol) and compound A-3-2 (15.2g, 44mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (17.4g, 125.8mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 3 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 16.3 g of Compound 1. (Yield 72%, MS: [M+H] + = 541)

합성예 2Synthesis Example 2

Figure pat00035
Figure pat00035

Trz2 (15g, 33.3mmol)와 화합물 A-3-1 (12.1g, 35mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(13.8g, 100mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 2시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 2를 15.6g 제조하였다. (수율 74%, MS: [M+H]+= 633)Trz2 (15g, 33.3mmol) and Compound A-3-1 (12.1g, 35mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (13.8g, 100mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 2 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 15.6 g of Compound 2. (Yield 74%, MS: [M+H] + = 633)

합성예 3Synthesis Example 3

Figure pat00036
Figure pat00036

Trz3 (15g, 34.6mmol)와 화합물 A-3-1 (12.6g, 36.4mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.4g, 103.9mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 2시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 3을 17.1g 제조하였다. (수율 80%, MS: [M+H]+= 616)Trz3 (15g, 34.6mmol) and Compound A-3-1 (12.6g, 36.4mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (14.4g, 103.9mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 2 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 17.1 g of Compound 3. (Yield 80%, MS: [M+H] + = 616)

합성예 4Synthesis Example 4

Figure pat00037
Figure pat00037

Trz4 (15g, 38.1mmol)와 화합물 A-3-1 (13.8g, 40mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(15.8g, 114.3mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 4를 17.3g 제조하였다. (수율 79%, MS: [M+H]+= 577)Trz4 (15g, 38.1mmol) and Compound A-3-1 (13.8g, 40mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (15.8g, 114.3mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 17.3 g of Compound 4. (Yield 79%, MS: [M+H] + = 577)

합성예 5Synthesis Example 5

Figure pat00038
Figure pat00038

Trz5 (15g, 38.1mmol)와 화합물 A-3-3 (13.8g, 40mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(15.8g, 114.3mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 5를 15.8g 제조하였다. (수율 72%, MS: [M+H]+= 577)Trz5 (15g, 38.1mmol) and compound A-3-3 (13.8g, 40mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (15.8g, 114.3mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 15.8 g of Compound 5. (Yield 72%, MS: [M+H] + = 577)

합성예 6Synthesis Example 6

Figure pat00039
Figure pat00039

Trz6 (15g, 43.6mmol)와 화합물 A-3-3 (15.8g, 45.8mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(18.1g, 130.9mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 6을 17.9g 제조하였다. (수율 78%, MS: [M+H]+= 527)Trz6 (15g, 43.6mmol) and compound A-3-3 (15.8g, 45.8mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (18.1g, 130.9mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 17.9 g of Compound 6. (Yield 78%, MS: [M+H] + = 527)

합성예 7Synthesis Example 7

Figure pat00040
Figure pat00040

Trz7 (15g, 34.6mmol)와 화합물 A-3-4 (12.6g, 36.4mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.4g, 103.9mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 7을 17.1g 제조하였다. (수율 80%, MS: [M+H]+= 616)Trz7 (15g, 34.6mmol) and compound A-3-4 (12.6g, 36.4mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (14.4g, 103.9mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 17.1 g of Compound 7. (Yield 80%, MS: [M+H] + = 616)

합성예 8Synthesis Example 8

Figure pat00041
Figure pat00041

Trz8 (15g, 35.9mmol)와 화합물 A-3-4 (13g, 37.7mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.9g, 107.7mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 2시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 8을 14.9g 제조하였다. (수율 69%, MS: [M+H]+= 601)Trz8 (15g, 35.9mmol) and compound A-3-4 (13g, 37.7mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (14.9g, 107.7mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 2 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.9 g of Compound 8. (Yield 69%, MS: [M+H] + = 601)

합성예 9Synthesis Example 9

Figure pat00042
Figure pat00042

Trz9 (15g, 36.8mmol)와 화합물 A-3-5 (13.3g, 38.6mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(15.2g, 110.3mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 9를 13.5g 제조하였다. (수율 62%, MS: [M+H]+= 591)Trz9 (15g, 36.8mmol) and Compound A-3-5 (13.3g, 38.6mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (15.2g, 110.3mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13.5 g of Compound 9. (Yield 62%, MS: [M+H] + = 591)

합성예 10Synthesis Example 10

Figure pat00043
Figure pat00043

Trz10 (15g, 43.6mmol)와 화합물 A-3-5 (15.8g, 45.8mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(18.1g, 130.9mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 10을 13.8g 제조하였다. (수율 60%, MS: [M+H]+= 527)Trz10 (15g, 43.6mmol) and Compound A-3-5 (15.8g, 45.8mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (18.1g, 130.9mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13.8 g of Compound 10. (Yield 60%, MS: [M+H] + = 527)

합성예 11Synthesis Example 11

Figure pat00044
Figure pat00044

Trz11 (15g, 56mmol)와 화합물 A-3-7 (20.3g, 58.8mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(23.2g, 168.1mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.3g, 0.6mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 11을 17.7g 제조하였다. (수율 70%, MS: [M+H]+= 451)Trz11 (15g, 56mmol) and compound A-3-7 (20.3g, 58.8mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (23.2g, 168.1mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.3g, 0.6mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 17.7 g of Compound 11. (Yield 70%, MS: [M+H] + = 451)

합성예 12Synthesis Example 12

Figure pat00045
Figure pat00045

Trz12 (15g, 38.1mmol)와 화합물 A-3-7 (13.8g, 40mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(15.8g, 114.3mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 2시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 12를 13.2g 제조하였다. (수율 60%, MS: [M+H]+= 577)Trz12 (15g, 38.1mmol) and compound A-3-7 (13.8g, 40mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (15.8g, 114.3mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 2 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13.2 g of Compound 12. (Yield 60%, MS: [M+H] + = 577)

합성예 13Synthesis Example 13

Figure pat00046
Figure pat00046

Trz13 (15g, 38.1mmol)와 화합물 A-2-2 (13.8g, 40mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(15.8g, 114.3mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 3시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 13을 17.3g 제조하였다. (수율 79%, MS: [M+H]+= 577)Trz13 (15g, 38.1mmol) and compound A-2-2 (13.8g, 40mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (15.8g, 114.3mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 3 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 17.3 g of Compound 13. (Yield 79%, MS: [M+H] + = 577)

합성예 14Synthesis Example 14

Figure pat00047
Figure pat00047

Trz14 (15g, 40.1mmol)와 화합물 A-2-2 (14.5g, 42.1mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(16.6g, 120.4mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 14를 13.8g 제조하였다. (수율 62%, MS: [M+H]+= 557)Trz14 (15g, 40.1mmol) and compound A-2-2 (14.5g, 42.1mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (16.6g, 120.4mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13.8 g of Compound 14. (Yield 62%, MS: [M+H] + = 557)

합성예 15Synthesis Example 15

Figure pat00048
Figure pat00048

Trz15 (15g, 33.8mmol)와 화합물 A-2-1 (12.2g, 35.5mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14g, 101.4mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 3시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 15를 15.7g 제조하였다. (수율 74%, MS: [M+H]+= 627)Trz15 (15g, 33.8mmol) and Compound A-2-1 (12.2g, 35.5mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (14g, 101.4mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 3 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 15.7 g of Compound 15. (Yield 74%, MS: [M+H] + = 627)

합성예 16Synthesis Example 16

Figure pat00049
Figure pat00049

Trz16 (15g, 40.8mmol)와 화합물 A-2-3 (14.8g, 42.8mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(16.9g, 122.3mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 16을 17.1g 제조하였다. (수율 76%, MS: [M+H]+= 551)Trz16 (15g, 40.8mmol) and compound A-2-3 (14.8g, 42.8mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (16.9g, 122.3mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 17.1 g of Compound 16. (Yield 76%, MS: [M+H] + = 551)

합성예 17Synthesis Example 17

Figure pat00050
Figure pat00050

Trz17 (15g, 35.9mmol)와 화합물 A-2-4 (13g, 37.7mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.9g, 107.7mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 3시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 17을 17.2g 제조하였다. (수율 80%, MS: [M+H]+= 601)Trz17 (15g, 35.9mmol) and Compound A-2-4 (13g, 37.7mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (14.9g, 107.7mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 3 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 17.2 g of compound 17. (Yield 80%, MS: [M+H] + = 601)

합성예 18Synthesis Example 18

Figure pat00051
Figure pat00051

Trz18 (15g, 35.9mmol)와 화합물 A-2-6 (13g, 37.7mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.9g, 107.7mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 18을 15.3g 제조하였다. (수율 71%, MS: [M+H]+= 601)Trz18 (15g, 35.9mmol) and compound A-2-6 (13g, 37.7mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (14.9g, 107.7mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 15.3 g of Compound 18. (Yield 71%, MS: [M+H] + = 601)

합성예 19Synthesis Example 19

Figure pat00052
Figure pat00052

Trz1 (15g, 41.9mmol)와 화합물 A-2-6 (15.2g, 44mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(17.4g, 125.8mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 19를 14.5g 제조하였다. (수율 64%, MS: [M+H]+= 541)Trz1 (15g, 41.9mmol) and compound A-2-6 (15.2g, 44mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (17.4g, 125.8mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.5 g of Compound 19. (Yield 64%, MS: [M+H] + = 541)

합성예 20Synthesis Example 20

Figure pat00053
Figure pat00053

Trz19 (15g, 34.6mmol)와 화합물 A-2-7 (12.6g, 36.4mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.4g, 103.9mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 3시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 20을 12.8g 제조하였다. (수율 60%, MS: [M+H]+= 616)Trz19 (15g, 34.6mmol) and compound A-2-7 (12.6g, 36.4mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (14.4g, 103.9mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 3 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 12.8 g of Compound 20. (Yield 60%, MS: [M+H] + = 616)

합성예 21Synthesis Example 21

Figure pat00054
Figure pat00054

Trz20 (15g, 41.9mmol)와 화합물 A-2-7 (15.2g, 44mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(17.4g, 125.8mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 3시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 21을 14.3g 제조하였다. (수율 63%, MS: [M+H]+= 541)Trz20 (15g, 41.9mmol) and Compound A-2-7 (15.2g, 44mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (17.4g, 125.8mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 3 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.3 g of Compound 21. (Yield 63%, MS: [M+H] + = 541)

합성예 22Synthesis Example 22

Figure pat00055
Figure pat00055

Trz21 (15g, 31mmol)와 화합물 A-1-2 (11.2g, 32.5mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(12.9g, 93mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 22를 15.1g 제조하였다. (수율 73%, MS: [M+H]+= 667)Trz21 (15g, 31mmol) and Compound A-1-2 (11.2g, 32.5mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (12.9g, 93mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 15.1 g of Compound 22. (Yield 73%, MS: [M+H] + = 667)

합성예 23Synthesis Example 23

Figure pat00056
Figure pat00056

Trz22 (15g, 41.9mmol)와 화합물 A-1-2 (15.2g, 44mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(17.4g, 125.8mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 23을 13.8g 제조하였다. (수율 61%, MS: [M+H]+= 541)Trz22 (15g, 41.9mmol) and compound A-1-2 (15.2g, 44mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (17.4g, 125.8mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13.8 g of Compound 23. (Yield 61%, MS: [M+H] + = 541)

합성예 24Synthesis Example 24

Figure pat00057
Figure pat00057

Trz17 (15g, 31mmol)와 화합물 A-1-1 (11.2g, 32.5mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(12.9g, 93mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 24를 11.3g 제조하였다. (수율 61%, MS: [M+H]+= 601)Trz17 (15g, 31mmol) and compound A-1-1 (11.2g, 32.5mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (12.9g, 93mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 11.3 g of Compound 24. (Yield 61%, MS: [M+H] + = 601)

합성예 25Synthesis Example 25

Figure pat00058
Figure pat00058

Trz23 (15g, 34.6mmol)와 화합물 A-1-4 (12.6g, 36.4mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.4g, 103.9mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 25를 17.1g 제조하였다. (수율 80%, MS: [M+H]+= 616)Trz23 (15g, 34.6mmol) and compound A-1-4 (12.6g, 36.4mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (14.4g, 103.9mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 17.1 g of Compound 25. (Yield 80%, MS: [M+H] + = 616)

합성예 26Synthesis Example 26

Figure pat00059
Figure pat00059

Trz18 (15g, 35.9mmol)와 화합물 A-1-4 (13g, 37.7mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.9g, 107.7mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 3시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 26을 14.2g 제조하였다. (수율 66%, MS: [M+H]+= 601)Trz18 (15g, 35.9mmol) and Compound A-1-4 (13g, 37.7mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (14.9g, 107.7mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 3 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.2 g of Compound 26. (Yield 66%, MS: [M+H] + = 601)

합성예 27Synthesis Example 27

Figure pat00060
Figure pat00060

Trz8 (15g, 35.9mmol)와 화합물 A-1-7 (13g, 37.7mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.9g, 107.7mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 27을 14.2g 제조하였다. (수율 66%, MS: [M+H]+= 601)Trz8 (15g, 35.9mmol) and Compound A-1-7 (13g, 37.7mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (14.9g, 107.7mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.2 g of Compound 27. (Yield 66%, MS: [M+H] + = 601)

합성예 28Synthesis Example 28

Figure pat00061
Figure pat00061

Trz24 (15g, 33.8mmol)와 화합물 A-1-7 (12.2g, 35.5mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14g, 101.4mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 3시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 28을 13.1g 제조하였다. (수율 62%, MS: [M+H]+= 627)Trz24 (15g, 33.8mmol) and Compound A-1-7 (12.2g, 35.5mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (14g, 101.4mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 3 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13.1 g of Compound 28. (Yield 62%, MS: [M+H] + = 627)

합성예 29Synthesis Example 29

Figure pat00062
Figure pat00062

Trz25 (15g, 31mmol)와 화합물 A-1-7 (11.2g, 32.5mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(12.9g, 93mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 29를 12.4g 제조하였다. (수율 60%, MS: [M+H]+= 667)Trz25 (15g, 31mmol) and compound A-1-7 (11.2g, 32.5mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (12.9g, 93mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 12.4 g of Compound 29. (Yield 60%, MS: [M+H] + = 667)

합성예 30Synthesis Example 30

Figure pat00063
Figure pat00063

Trz26 (15g, 42mmol)와 화합물 A-4-3 (15.2g, 44.1mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(17.4g, 126.1mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 30을 15.9g 제조하였다. (수율 70%, MS: [M+H]+= 540)Trz26 (15g, 42mmol) and compound A-4-3 (15.2g, 44.1mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (17.4g, 126.1mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 15.9 g of Compound 30. (Yield 70%, MS: [M+H] + = 540)

합성예 31Synthesis Example 31

Figure pat00064
Figure pat00064

Trz27 (15g, 35.9mmol)와 화합물 A-4-3 (13g, 37.7mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.9g, 107.7mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 31을 14.6g 제조하였다. (수율 68%, MS: [M+H]+= 601)Trz27 (15g, 35.9mmol) and compound A-4-3 (13g, 37.7mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (14.9g, 107.7mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.6 g of Compound 31. (Yield 68%, MS: [M+H] + = 601)

합성예 32Synthesis Example 32

Figure pat00065
Figure pat00065

Trz28 (15g, 30.4mmol)와 화합물 A-4-3 (11g, 31.9mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(12.6g, 91.1mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 32를 14.8g 제조하였다. (수율 72%, MS: [M+H]+= 677)Trz28 (15g, 30.4mmol) and compound A-4-3 (11g, 31.9mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (12.6g, 91.1mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.8 g of Compound 32. (Yield 72%, MS: [M+H] + = 677)

합성예 33Synthesis Example 33

Figure pat00066
Figure pat00066

Trz29 (15g, 41.9mmol)와 화합물 A-4-2 (15.2g, 44mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(17.4g, 125.8mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 2시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 33을 15.9g 제조하였다. (수율 70%, MS: [M+H]+= 541)Trz29 (15g, 41.9mmol) and compound A-4-2 (15.2g, 44mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (17.4g, 125.8mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 2 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 15.9 g of Compound 33. (Yield 70%, MS: [M+H] + = 541)

합성예 34Synthesis Example 34

Figure pat00067
Figure pat00067

Trz30 (15g, 40.8mmol)와 화합물 A-4-2 (14.8g, 42.8mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(16.9g, 122.3mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 34를 14.6g 제조하였다. (수율 65%, MS: [M+H]+= 551)Trz30 (15g, 40.8mmol) and compound A-4-2 (14.8g, 42.8mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (16.9g, 122.3mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.6 g of Compound 34. (Yield 65%, MS: [M+H] + = 551)

합성예 35Synthesis Example 35

Figure pat00068
Figure pat00068

Trz31 (15g, 40.8mmol)와 화합물 A-4-1 (14.8g, 42.8mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(16.9g, 122.3mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 35를 13.7g 제조하였다. (수율 61%, MS: [M+H]+= 551)Trz31 (15g, 40.8mmol) and compound A-4-1 (14.8g, 42.8mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (16.9g, 122.3mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13.7 g of Compound 35. (Yield 61%, MS: [M+H] + = 551)

합성예 36Synthesis Example 36

Figure pat00069
Figure pat00069

Trz32 (15g, 40.1mmol)와 화합물 A-4-5 (14.5g, 42.1mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(16.6g, 120.4mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 2시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 36을 18.8g 제조하였다. (수율 78%, MS: [M+H]+= 603)Trz32 (15g, 40.1mmol) and compound A-4-5 (14.5g, 42.1mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (16.6g, 120.4mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 2 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 18.8 g of Compound 36. (Yield 78%, MS: [M+H] + = 603)

합성예 37Synthesis Example 37

Figure pat00070
Figure pat00070

Trz9 (15g, 36.8mmol)와 화합물 A-4-5 (13.3g, 38.6mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(15.2g, 110.3mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 2시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 37을 16.3g 제조하였다. (수율 75%, MS: [M+H]+= 591)Trz9 (15g, 36.8mmol) and compound A-4-5 (13.3g, 38.6mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (15.2g, 110.3mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 2 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 16.3 g of Compound 37. (Yield 75%, MS: [M+H] + = 591)

합성예 38Synthesis Example 38

Figure pat00071
Figure pat00071

Trz8 (15g, 35.9mmol)와 화합물 A-4-5 (13g, 37.7mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.9g, 107.7mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 38을 16.2g 제조하였다. (수율 75%, MS: [M+H]+= 601)Trz8 (15g, 35.9mmol) and compound A-4-5 (13g, 37.7mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (14.9g, 107.7mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 16.2 g of Compound 38. (Yield 75%, MS: [M+H] + = 601)

합성예 39Synthesis Example 39

Figure pat00072
Figure pat00072

Trz33 (15g, 35.7mmol)와 화합물 A-5-3 (12.9g, 37.5mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.8g, 107.2mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 39를 15.5g 제조하였다. (수율 72%, MS: [M+H]+= 603)Trz33 (15g, 35.7mmol) and compound A-5-3 (12.9g, 37.5mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (14.8g, 107.2mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 15.5 g of Compound 39. (Yield 72%, MS: [M+H] + = 603)

합성예 40Synthesis Example 40

Figure pat00073
Figure pat00073

Trz34 (15g, 35.9mmol)와 화합물 A-5-3 (13g, 37.7mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.9g, 107.7mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 40을 14g 제조하였다. (수율 65%, MS: [M+H]+= 601)Trz34 (15g, 35.9mmol) and compound A-5-3 (13g, 37.7mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (14.9g, 107.7mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14 g of Compound 40. (Yield 65%, MS: [M+H] + = 601)

합성예 41Synthesis Example 41

Figure pat00074
Figure pat00074

Trz35 (15g, 38.1mmol)와 화합물 A-5-3 (13.8g, 40mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(15.8g, 114.3mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 41을 16g 제조하였다. (수율 73%, MS: [M+H]+= 577)Trz35 (15g, 38.1mmol) and compound A-5-3 (13.8g, 40mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (15.8g, 114.3mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 16 g of Compound 41. (Yield 73%, MS: [M+H] + = 577)

합성예 42Synthesis Example 42

Figure pat00075
Figure pat00075

Trz36 (15g, 35.9mmol)와 화합물 A-5-2 (13g, 37.7mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.9g, 107.7mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 3시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 42를 15.3g 제조하였다. (수율 71%, MS: [M+H]+= 601)Trz36 (15g, 35.9mmol) and compound A-5-2 (13g, 37.7mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (14.9g, 107.7mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 3 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 15.3 g of Compound 42. (Yield 71%, MS: [M+H] + = 601)

합성예 43Synthesis Example 43

Figure pat00076
Figure pat00076

Trz31 (15g, 40.8mmol)와 화합물 A-5-4 (14.8g, 42.8mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(16.9g, 122.3mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 3시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 43을 14.6g 제조하였다. (수율 65%, MS: [M+H]+= 551)Trz31 (15g, 40.8mmol) and compound A-5-4 (14.8g, 42.8mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (16.9g, 122.3mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 3 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.6 g of Compound 43. (Yield 65%, MS: [M+H] + = 551)

합성예 44Synthesis Example 44

Figure pat00077
Figure pat00077

Trz37 (15g, 35.4mmol)와 화합물 A-5-5 (12.8g, 37.2mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.7g, 106.2mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 3시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 44를 15.4g 제조하였다. (수율 72%, MS: [M+H]+= 607)Trz37 (15g, 35.4mmol) and compound A-5-5 (12.8g, 37.2mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (14.7g, 106.2mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 3 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 15.4 g of Compound 44. (Yield 72%, MS: [M+H] + = 607)

합성예 45Synthesis Example 45

Figure pat00078
Figure pat00078

Trz38 (15g, 38.1mmol)와 화합물 A-5-6 (13.8g, 40mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(15.8g, 114.3mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 45를 16.2g 제조하였다. (수율 74%, MS: [M+H]+= 577)Trz38 (15g, 38.1mmol) and compound A-5-6 (13.8g, 40mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (15.8g, 114.3mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 16.2 g of Compound 45. (Yield 74%, MS: [M+H] + = 577)

합성예 46Synthesis Example 46

Figure pat00079
Figure pat00079

Trz9 (15g, 36.8mmol)와 화합물 A-5-6 (13.3g, 38.6mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(15.2g, 110.3mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 46을 14.3g 제조하였다. (수율 66%, MS: [M+H]+= 591)Trz9 (15g, 36.8mmol) and compound A-5-6 (13.3g, 38.6mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (15.2g, 110.3mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.3 g of Compound 46. (Yield 66%, MS: [M+H] + = 591)

합성예 47Synthesis Example 47

Figure pat00080
Figure pat00080

Trz39 (15g, 33.8mmol)와 화합물 A-5-6 (12.2g, 35.5mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14g, 101.4mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 47을 16.7g 제조하였다. (수율 79%, MS: [M+H]+= 627)Trz39 (15g, 33.8mmol) and compound A-5-6 (12.2g, 35.5mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (14g, 101.4mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 16.7 g of Compound 47. (Yield 79%, MS: [M+H] + = 627)

합성예 48Synthesis Example 48

Figure pat00081
Figure pat00081

Trz40 (15g, 31mmol)와 화합물 A-6-3 (11.2g, 32.5mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(12.9g, 93mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 48을 16.1g 제조하였다. (수율 78%, MS: [M+H]+= 667)Trz40 (15g, 31mmol) and compound A-6-3 (11.2g, 32.5mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (12.9g, 93mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 16.1 g of Compound 48. (Yield 78%, MS: [M+H] + = 667)

합성예 49Synthesis Example 49

Figure pat00082
Figure pat00082

Trz41 (15g, 32.1mmol)와 화합물 A-6-1 (11.6g, 33.7mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(13.3g, 96.2mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 3시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 49를 12.5g 제조하였다. (수율 60%, MS: [M+H]+= 651)Trz41 (15g, 32.1mmol) and Compound A-6-1 (11.6g, 33.7mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (13.3g, 96.2mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 3 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 12.5 g of Compound 49. (Yield 60%, MS: [M+H] + = 651)

합성예 50Synthesis Example 50

Figure pat00083
Figure pat00083

Trz42 (15g, 38.1mmol)와 화합물 A-6-4 (13.8g, 40mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(15.8g, 114.3mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 2시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 50을 17.3g 제조하였다. (수율 79%, MS: [M+H]+= 577)Trz42 (15g, 38.1mmol) and compound A-6-4 (13.8g, 40mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (15.8g, 114.3mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 2 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 17.3 g of Compound 50. (Yield 79%, MS: [M+H] + = 577)

합성예 51Synthesis Example 51

Figure pat00084
Figure pat00084

Trz43 (15g, 35.9mmol)와 화합물 A-6-4 (13g, 37.7mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.9g, 107.7mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 3시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 51을 14.2g 제조하였다. (수율 66%, MS: [M+H]+= 601)Trz43 (15g, 35.9mmol) and compound A-6-4 (13g, 37.7mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (14.9g, 107.7mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 3 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.2 g of Compound 51. (Yield 66%, MS: [M+H] + = 601)

합성예 52Synthesis Example 52

Figure pat00085
Figure pat00085

Trz18 (15g, 35.9mmol)와 화합물 A-6-5 (13g, 37.7mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.9g, 107.7mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 52를 14g 제조하였다. (수율 65%, MS: [M+H]+= 601)Trz18 (15g, 35.9mmol) and compound A-6-5 (13g, 37.7mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (14.9g, 107.7mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14 g of compound 52. (Yield 65%, MS: [M+H] + = 601)

합성예 53Synthesis Example 53

Figure pat00086
Figure pat00086

Trz18 (15g, 41.9mmol)와 화합물 A-6-5 (15.2g, 44mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(17.4g, 125.8mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 53을 13.8g 제조하였다. (수율 61%, MS: [M+H]+= 541)Trz18 (15g, 41.9mmol) and compound A-6-5 (15.2g, 44mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (17.4g, 125.8mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13.8 g of compound 53. (Yield 61%, MS: [M+H] + = 541)

합성예 54Synthesis Example 54

Figure pat00087
Figure pat00087

Trz17 (15g, 35.9mmol)와 화합물 A-6-6 (13g, 37.7mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.9g, 107.7mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 54를 16.2g 제조하였다. (수율 75%, MS: [M+H]+= 601)Trz17 (15g, 35.9mmol) and compound A-6-6 (13g, 37.7mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (14.9g, 107.7mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 16.2 g of Compound 54. (Yield 75%, MS: [M+H] + = 601)

합성예 55Synthesis Example 55

Figure pat00088
Figure pat00088

Trz44 (15g, 38.1mmol)와 화합물 A-6-6 (13.8g, 40mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(15.8g, 114.3mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 55를 15.1g 제조하였다. (수율 69%, MS: [M+H]+= 577)Trz44 (15g, 38.1mmol) and compound A-6-6 (13.8g, 40mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (15.8g, 114.3mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 15.1 g of compound 55. (Yield 69%, MS: [M+H] + = 577)

합성예 56Synthesis Example 56

Figure pat00089
Figure pat00089

Trz32 (15g, 35.7mmol)와 화합물 A-7-3 (12.9g, 37.5mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.8g, 107.2mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 2시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 56을 14.8g 제조하였다. (수율 69%, MS: [M+H]+= 603)Trz32 (15g, 35.7mmol) and compound A-7-3 (12.9g, 37.5mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (14.8g, 107.2mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 2 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.8 g of compound 56. (Yield 69%, MS: [M+H] + = 603)

합성예 57Synthesis Example 57

Figure pat00090
Figure pat00090

Trz18 (15g, 35.9mmol)와 화합물 A-7-3 (13g, 37.7mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.9g, 107.7mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 3시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 57을 16.2g 제조하였다. (수율 75%, MS: [M+H]+= 601)Trz18 (15g, 35.9mmol) and compound A-7-3 (13g, 37.7mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (14.9g, 107.7mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 3 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 16.2 g of Compound 57. (Yield 75%, MS: [M+H] + = 601)

합성예 58Synthesis Example 58

Figure pat00091
Figure pat00091

Trz45 (15g, 29.5mmol)와 화합물 A-7-1 (10.7g, 30.9mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(12.2g, 88.4mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 2시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 58을 16.3g 제조하였다. (수율 80%, MS: [M+H]+= 692)Trz45 (15g, 29.5mmol) and Compound A-7-1 (10.7g, 30.9mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (12.2g, 88.4mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 2 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 16.3 g of compound 58. (Yield 80%, MS: [M+H] + = 692)

합성예 59Synthesis Example 59

Figure pat00092
Figure pat00092

Trz46 (15g, 35.9mmol)와 화합물 A-7-4 (13g, 37.7mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.9g, 107.7mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 2시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 59를 13.1g 제조하였다. (수율 61%, MS: [M+H]+= 601)Trz46 (15g, 35.9mmol) and compound A-7-4 (13g, 37.7mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (14.9g, 107.7mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 2 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13.1 g of compound 59. (Yield 61%, MS: [M+H] + = 601)

합성예 60Synthesis Example 60

Figure pat00093
Figure pat00093

Trz47 (15g, 33.8mmol)와 화합물 A-7-4 (12.2g, 35.5mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14g, 101.4mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 2시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 60을 12.9g 제조하였다. (수율 61%, MS: [M+H]+= 627)Trz47 (15g, 33.8mmol) and compound A-7-4 (12.2g, 35.5mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (14g, 101.4mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 2 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 12.9 g of compound 60. (Yield 61%, MS: [M+H] + = 627)

합성예 61Synthesis Example 61

Figure pat00094
Figure pat00094

Trz48 (15g, 32.1mmol)와 화합물 A-7-5 (11.6g, 33.7mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(13.3g, 96.2mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 2시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 61을 13.5g 제조하였다. (수율 65%, MS: [M+H]+= 651)Trz48 (15g, 32.1mmol) and compound A-7-5 (11.6g, 33.7mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (13.3g, 96.2mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 2 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13.5 g of compound 61. (Yield 65%, MS: [M+H] + = 651)

합성예 62Synthesis Example 62

Figure pat00095
Figure pat00095

Trz42 (15g, 38.1mmol)와 화합물 A-7-5 (13.8g, 40mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(15.8g, 114.3mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 3시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 62를 15.4g 제조하였다. (수율 70%, MS: [M+H]+= 577)Trz42 (15g, 38.1mmol) and compound A-7-5 (13.8g, 40mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (15.8g, 114.3mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 3 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 15.4 g of Compound 62. (Yield 70%, MS: [M+H] + = 577)

합성예 63Synthesis Example 63

Figure pat00096
Figure pat00096

Trz42 (15g, 38.1mmol)와 화합물 A-8-3 (13.8g, 40mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(15.8g, 114.3mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 63을 13.8g 제조하였다. (수율 63%, MS: [M+H]+= 577)Trz42 (15g, 38.1mmol) and compound A-8-3 (13.8g, 40mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (15.8g, 114.3mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13.8 g of compound 63. (Yield 63%, MS: [M+H] + = 577)

합성예 64Synthesis Example 64

Figure pat00097
Figure pat00097

Trz49 (15g, 31.1mmol)와 화합물 A-8-3 (11.3g, 32.6mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(12.9g, 93.2mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 2시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 64를 13.2g 제조하였다. (수율 64%, MS: [M+H]+= 666)Trz49 (15g, 31.1mmol) and compound A-8-3 (11.3g, 32.6mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (12.9g, 93.2mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 2 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13.2 g of Compound 64. (Yield 64%, MS: [M+H] + = 666)

합성예 65Synthesis Example 65

Figure pat00098
Figure pat00098

Trz9 (15g, 36.8mmol)와 화합물 A-8-2 (13.3g, 38.6mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(15.2g, 110.3mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 65를 13g 제조하였다. (수율 60%, MS: [M+H]+= 591)Trz9 (15g, 36.8mmol) and compound A-8-2 (13.3g, 38.6mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (15.2g, 110.3mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13 g of compound 65. (Yield 60%, MS: [M+H] + = 591)

합성예 66Synthesis Example 66

Figure pat00099
Figure pat00099

Trz50 (15g, 35.4mmol)와 화합물 A-8-1 (12.8g, 37.2mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.7g, 106.2mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 3시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 66을 17.9g 제조하였다. (수율 75%, MS: [M+H]+= 677)Trz50 (15g, 35.4mmol) and compound A-8-1 (12.8g, 37.2mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (14.7g, 106.2mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 3 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 17.9 g of compound 66. (Yield 75%, MS: [M+H] + = 677)

합성예 67Synthesis Example 67

Figure pat00100
Figure pat00100

Trz51 (15g, 35.4mmol)와 화합물 A-8-4 (12.8g, 37.2mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.7g, 106.2mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 67을 13.7g 제조하였다. (수율 64%, MS: [M+H]+= 607)Trz51 (15g, 35.4mmol) and compound A-8-4 (12.8g, 37.2mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (14.7g, 106.2mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13.7 g of compound 67. (Yield 64%, MS: [M+H] + = 607)

합성예 68Synthesis Example 68

Figure pat00101
Figure pat00101

Trz52 (15g, 43.6mmol)와 화합물 A-8-5 (15.8g, 45.8mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(18.1g, 130.9mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 3시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 68을 17.4g 제조하였다. (수율 76%, MS: [M+H]+= 527)Trz52 (15g, 43.6mmol) and compound A-8-5 (15.8g, 45.8mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (18.1g, 130.9mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 3 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 17.4 g of compound 68. (Yield 76%, MS: [M+H] + = 527)

합성예 69Synthesis Example 69

Figure pat00102
Figure pat00102

Trz53 (15g, 30.4mmol)와 화합물 A-8-5 (11g, 31.9mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(12.6g, 91.1mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 3시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 69를 13.8g 제조하였다. (수율 67%, MS: [M+H]+= 677)Trz53 (15g, 30.4mmol) and compound A-8-5 (11g, 31.9mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (12.6g, 91.1mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 3 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13.8 g of Compound 69. (Yield 67%, MS: [M+H] + = 677)

합성예 70Synthesis Example 70

Figure pat00103
Figure pat00103

Trz54 (15g, 35.7mmol)와 화합물 A-9-3 (12.9g, 37.5mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.8g, 107.2mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 3시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 70을 14.4g 제조하였다. (수율 67%, MS: [M+H]+= 603)Trz54 (15g, 35.7mmol) and compound A-9-3 (12.9g, 37.5mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (14.8g, 107.2mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 3 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.4 g of Compound 70. (Yield 67%, MS: [M+H] + = 603)

합성예 71Synthesis Example 71

Figure pat00104
Figure pat00104

Trz55 (15g, 30.4mmol)와 화합물 A-9-3 (11g, 31.9mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(12.6g, 91.1mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 71을 13.6g 제조하였다. (수율 66%, MS: [M+H]+= 677)Trz55 (15g, 30.4mmol) and compound A-9-3 (11g, 31.9mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (12.6g, 91.1mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13.6 g of compound 71. (Yield 66%, MS: [M+H] + = 677)

합성예 72Synthesis Example 72

Figure pat00105
Figure pat00105

Trz56 (15g, 30.4mmol)와 화합물 A-9-1 (11g, 31.9mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(12.6g, 91.1mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 72를 13.3g 제조하였다. (수율 65%, MS: [M+H]+= 677)Trz56 (15g, 30.4mmol) and compound A-9-1 (11g, 31.9mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (12.6g, 91.1mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13.3 g of Compound 72. (Yield 65%, MS: [M+H] + = 677)

합성예 73Synthesis Example 73

Figure pat00106
Figure pat00106

Trz57 (15g, 30.4mmol)와 화합물 A-9-4 (11g, 31.9mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(12.6g, 91.1mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 3시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 73을 15.2g 제조하였다. (수율 74%, MS: [M+H]+= 677)Trz57 (15g, 30.4mmol) and compound A-9-4 (11g, 31.9mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (12.6g, 91.1mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 3 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 15.2 g of Compound 73. (Yield 74%, MS: [M+H] + = 677)

합성예 74Synthesis Example 74

Figure pat00107
Figure pat00107

Trz58 (15g, 29.5mmol)와 화합물 A-9-5 (10.7g, 30.9mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(12.2g, 88.4mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 2시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 74를 15.1g 제조하였다. (수율 74%, MS: [M+H]+= 692)Trz58 (15g, 29.5mmol) and compound A-9-5 (10.7g, 30.9mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (12.2g, 88.4mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 2 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 15.1 g of Compound 74. (Yield 74%, MS: [M+H] + = 692)

합성예 75Synthesis Example 75

Figure pat00108
Figure pat00108

Trz18 (15g, 35.9mmol)와 화합물 A-9-5 (13g, 37.7mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.9g, 107.7mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 2시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 75를 15.5g 제조하였다. (수율 72%, MS: [M+H]+= 601)Trz18 (15g, 35.9mmol) and compound A-9-5 (13g, 37.7mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (14.9g, 107.7mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 2 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 15.5 g of Compound 75. (Yield 72%, MS: [M+H] + = 601)

합성예 76Synthesis Example 76

Figure pat00109
Figure pat00109

Trz59 (15g, 38.1mmol)와 화합물 A-10-3 (13.8g, 40mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(15.8g, 114.3mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 76을 17.6g 제조하였다. (수율 80%, MS: [M+H]+= 577)Trz59 (15g, 38.1mmol) and compound A-10-3 (13.8g, 40mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (15.8g, 114.3mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 17.6 g of compound 76. (Yield 80%, MS: [M+H] + = 577)

합성예 77Synthesis Example 77

Figure pat00110
Figure pat00110

Trz60 (15g, 38.1mmol)와 화합물 A-10-3 (13.8g, 40mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(15.8g, 114.3mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 77을 13.6g 제조하였다. (수율 62%, MS: [M+H]+= 577)Trz60 (15g, 38.1mmol) and compound A-10-3 (13.8g, 40mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (15.8g, 114.3mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 13.6 g of Compound 77. (Yield 62%, MS: [M+H] + = 577)

합성예 78Synthesis Example 78

Figure pat00111
Figure pat00111

Trz61 (15g, 35.4mmol)와 화합물 A-10-2 (12.8g, 37.2mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.7g, 106.2mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 2시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 78을 15.4g 제조하였다. (수율 72%, MS: [M+H]+= 607)Trz61 (15g, 35.4mmol) and compound A-10-2 (12.8g, 37.2mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (14.7g, 106.2mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 2 hours, it was cooled to room temperature, and the organic layer and the water layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 15.4 g of Compound 78. (Yield 72%, MS: [M+H] + = 607)

합성예 79Synthesis Example 79

Figure pat00112
Figure pat00112

Trz63 (15g, 43.6mmol)와 화합물 A-10-1 (15.8g, 45.8mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(18.1g, 130.9mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 79를 14.9g 제조하였다. (수율 65%, MS: [M+H]+= 527)Trz63 (15g, 43.6mmol) and compound A-10-1 (15.8g, 45.8mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (18.1g, 130.9mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.9 g of compound 79. (Yield 65%, MS: [M+H] + = 527)

합성예 80Synthesis Example 80

Figure pat00113
Figure pat00113

Trz32 (15g, 35.7mmol)와 화합물 A-10-4 (12.9g, 37.5mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.8g, 107.2mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 80을 14.4g 제조하였다. (수율 67%, MS: [M+H]+= 603)Trz32 (15g, 35.7mmol) and compound A-10-4 (12.9g, 37.5mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (14.8g, 107.2mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.4 g of Compound 80. (Yield 67%, MS: [M+H] + = 603)

합성예 81Synthesis Example 81

Figure pat00114
Figure pat00114

Trz64 (15g, 35.9mmol)와 화합물 A-10-4 (13g, 37.7mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(14.9g, 107.7mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 81을 12.9g 제조하였다. (수율 60%, MS: [M+H]+= 601)Trz64 (15g, 35.9mmol) and compound A-10-4 (13g, 37.7mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (14.9g, 107.7mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 12.9 g of compound 81. (Yield 60%, MS: [M+H] + = 601)

합성예 82Synthesis Example 82

Figure pat00115
Figure pat00115

Trz65 (15g, 31.1mmol)와 화합물 A-10-4 (11.3g, 32.6mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(12.9g, 93.2mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol)을 투입하였다. 3시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 82를 14.9g 제조하였다. (수율 72%, MS: [M+H]+= 666)Trz65 (15g, 31.1mmol) and compound A-10-4 (11.3g, 32.6mmol) were added to 300ml of THF and stirred and refluxed. Thereafter, potassium carbonate (12.9g, 93.2mmol) was dissolved in 100ml of water, and after sufficiently stirred, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.3mmol) was added. After reacting for 3 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.9 g of compound 82. (Yield 72%, MS: [M+H] + = 666)

합성예 83Synthesis Example 83

Figure pat00116
Figure pat00116

Trz6 (15g, 43.6mmol)와 화합물 A-10-5 (15.8g, 45.8mmol)를 THF 300ml에 넣고 교반 및 환류하였다. 이 후 potassium carbonate(18.1g, 130.9mmol)를 물 100ml에 녹여 투입하고 충분히 교반한 후 bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol)을 투입하였다. 5시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 83을 18.1g 제조하였다. (수율 79%, MS: [M+H]+= 527)Trz6 (15g, 43.6mmol) and compound A-10-5 (15.8g, 45.8mmol) were added to 300ml of THF, stirred and refluxed. Thereafter, potassium carbonate (18.1g, 130.9mmol) was dissolved in 100ml of water, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.2g, 0.4mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 18.1 g of compound 83. (Yield 79%, MS: [M+H] + = 527)

실시예 1Example 1

ITO(indium tin oxide)가 1,000Å의 두께로 박막 코팅된 유리 기판을 세제를 녹인 증류수에 넣고 초음파로 세척했다. 이때, 세제로는 피셔사(Fischer Co.) 제품을 사용하였으며, 증류수로는 밀러포어사(Millipore Co.) 제품의 필터(Filter)로 2차로 걸러진 증류수를 사용했다. ITO를 30분간 세척한 후 증류수로 2회 반복하여 초음파 세척을 10분간 진행했다. 증류수 세척이 끝난 후, 이소프로필알콜, 아세톤, 메탄올의 용제로 초음파 세척을 하고 건조시킨 후 플라즈마 세정기로 수송시켰다. 또한, 산소 플라즈마를 이용하여 상기 기판을 5분간 세정한 후 진공 증착기로 기판을 수송시켰다.A glass substrate coated with ITO (indium tin oxide) to a thickness of 1,000 Å was put in distilled water in which detergent was dissolved and washed with ultrasonic waves. At this time, a Fischer Co. product was used as the detergent, and distilled water filtered through a second filter of a Millipore Co. product was used as the distilled water. After washing the ITO for 30 minutes, it was repeated twice with distilled water and ultrasonic cleaning was performed for 10 minutes. After washing with distilled water, ultrasonic cleaning was performed with solvents such as isopropyl alcohol, acetone, and methanol, dried, and transported to a plasma cleaner. In addition, after cleaning the substrate for 5 minutes using oxygen plasma, the substrate was transferred to a vacuum deposition machine.

이렇게 준비된 ITO 투명 전극 위에 정공주입층으로 하기 HI-1 화합물을 1150Å의 두께로 형성하되 하기 A-1 화합물을 1.5% 농도로 p-doping 했다. 상기 정공주입층 위에 하기 HT-1 화합물을 진공 증착하여 막 두께 800Å의 정공수송층을 형성했다. 이어서, 상기 정공수송층 위에 막 두께 150Å으로 하기 EB-1 화합물을 진공 증착하여 전자차단층을 형성했다. 이어서, 상기 EB-1 증착막 위에 호스트로 하기 화합물 1과 도판트로 Dp-7 화합물을 98:2의 중량비로 진공 증착하여 400Å 두께의 적색 발광층을 형성했다. 상기 발광층 위에 막 두께 30Å으로 하기 HB-1 화합물을 진공 증착하여 정공저지층을 형성했다. 이어서, 상기 정공저지층 위에 하기 ET-1 화합물과 하기 LiQ 화합물을 2:1의 중량비로 진공 증착하여 300Å의 두께로 전자주입 및 수송층을 형성했다. 상기 전자주입 및 수송층 위에 순차적으로 12Å 두께로 리튬플로라이드(LiF)와 1,000Å 두께로 알루미늄을 증착하여 음극을 형성했다. The following compound HI-1 was formed to a thickness of 1150 Å as a hole injection layer on the prepared ITO transparent electrode, but the following compound A-1 was p-doped at a concentration of 1.5%. On the hole injection layer, the following HT-1 compound was vacuum deposited to form a hole transport layer having a thickness of 800 Å. Subsequently, an electron blocking layer was formed by vacuum depositing the following EB-1 compound to a film thickness of 150 Å on the hole transport layer. Then, on the EB-1 deposited film, Compound 1 as a host and Compound Dp-7 as a dopant were vacuum deposited at a weight ratio of 98:2 to form a red light emitting layer having a thickness of 400 Å. A hole blocking layer was formed on the light emitting layer by vacuum depositing the following HB-1 compound to a film thickness of 30 Å. Subsequently, the following ET-1 compound and the following LiQ compound were vacuum deposited at a weight ratio of 2:1 on the hole blocking layer to form an electron injection and transport layer with a thickness of 300 Å. A negative electrode was formed by sequentially depositing lithium fluoride (LiF) to a thickness of 12 Å and aluminum to a thickness of 1,000 Å on the electron injection and transport layer.

Figure pat00117
Figure pat00117

상기의 과정에서 유기물의 증착속도는 0.4~0.7Å/sec를 유지하였고, 음극의 리튬플로라이드는 0.3Å/sec, 알루미늄은 2Å/sec의 증착 속도를 유지하였으며, 증착시 진공도는 2ⅹ10-7 ~ 5ⅹ10-6 torr를 유지하여, 유기 발광 소자를 제조하였다.In the above process, the deposition rate of the organic material was maintained at 0.4 ~ 0.7Å / sec, the deposition rate of lithium fluoride on the cathode was 0.3Å / sec, and the deposition rate of aluminum was 2Å / sec, and the vacuum level during deposition was 2ⅹ10 -7 ~ Maintaining 5x10 -6 torr, an organic light emitting device was manufactured.

실시예 2 내지 실시예 83Examples 2 to 83

상기 실시예 1에서 하기 표 1에 기재된 화합물을 사용하는 것을 제외하고는, 상기 실시예 1과 동일한 방법으로 유기 발광 소자를 제조하였다. An organic light emitting device was manufactured in the same manner as in Example 1, except for using the compounds listed in Table 1 below in Example 1.

비교예 1 내지 비교예 12Comparative Examples 1 to 12

상기 실시예 1에서 하기 표 1에 기재된 화합물을 사용하는 것을 제외하고는, 상기 실시예 1과 동일한 방법으로 유기 발광 소자를 제조하였다. 하기 표 1의 화합물 B-1 내지 B-12는 하기와 같다.An organic light emitting device was manufactured in the same manner as in Example 1, except for using the compounds listed in Table 1 below in Example 1. Compounds B-1 to B-12 in Table 1 are as follows.

Figure pat00118
Figure pat00118

상기 실시예 1 내지 실시예 83 및 비교예 1 내지 비교예 12에서 제조한 유기 발광 소자에 전류를 인가하였을 때, 전압, 효율을 측정(15mA/cm2 기준)하고 그 결과를 하기 표1 내지 표2에 나타냈다. 수명 T95는 휘도가 초기 휘도(6,000 nit)에서 95%로 감소되는데 소요되는 시간을 의미한다.When current was applied to the organic light emitting devices prepared in Examples 1 to 83 and Comparative Examples 1 to 12, voltage and efficiency were measured (based on 15 mA/cm 2 ) and the results are shown in Tables 1 to 12 below. shown in 2. The lifetime T95 means the time required for the luminance to decrease from the initial luminance (6,000 nit) to 95%.

구분division 호스트host 구동전압(V)Driving voltage (V) 효율(cd/A)Efficiency (cd/A) 수명 T95(hr)Lifetime T95(hr) 발광색luminescent color 실시예 1Example 1 화합물 1compound 1 3.583.58 21.3121.31 158158 적색Red 실시예 2Example 2 화합물 2compound 2 3.573.57 20.2320.23 168168 적색Red 실시예 3Example 3 화합물 3compound 3 3.553.55 20.7620.76 172172 적색Red 실시예 4Example 4 화합물 4compound 4 3.593.59 20.9220.92 173173 적색Red 실시예 5Example 5 화합물 5compound 5 3.563.56 20.7020.70 157157 적색Red 실시예 6Example 6 화합물 6compound 6 3.563.56 20.8320.83 153153 적색Red 실시예 7Example 7 화합물 7compound 7 3.563.56 20.2220.22 155155 적색Red 실시예 8Example 8 화합물 8compound 8 3.583.58 21.4121.41 163163 적색Red 실시예 9Example 9 화합물 9compound 9 3.573.57 21.4021.40 159159 적색Red 실시예 10Example 10 화합물 10compound 10 3.603.60 20.2120.21 160160 적색Red 실시예 11Example 11 화합물 11compound 11 3.613.61 21.4421.44 172172 적색Red 실시예 12Example 12 화합물 12compound 12 3.553.55 21.1921.19 158158 적색Red 실시예 13Example 13 화합물 13compound 13 3.513.51 22.0922.09 189189 적색Red 실시예 14Example 14 화합물 14compound 14 3.413.41 21.8021.80 176176 적색Red 실시예 15Example 15 화합물 15compound 15 3.533.53 22.1122.11 184184 적색Red 실시예 16Example 16 화합물 16compound 16 3.433.43 22.1922.19 191191 적색Red 실시예 17Example 17 화합물 17compound 17 3.553.55 21.7821.78 184184 적색Red 실시예 18Example 18 화합물 18compound 18 3.533.53 21.3521.35 179179 적색Red 실시예 19Example 19 화합물 19compound 19 3.533.53 21.2521.25 193193 적색Red 실시예 20Example 20 화합물 20compound 20 3.473.47 22.1522.15 184184 적색Red 실시예 21Example 21 화합물 21compound 21 3.433.43 21.9721.97 187187 적색Red 실시예 22Example 22 화합물 22compound 22 3.403.40 22.4122.41 212212 적색Red 실시예 23Example 23 화합물 23compound 23 3.333.33 23.3523.35 216216 적색Red 실시예 24Example 24 화합물 24compound 24 3.373.37 22.5722.57 222222 적색Red 실시예 25Example 25 화합물 25compound 25 3.323.32 22.3422.34 199199 적색Red 실시예 26Example 26 화합물 26compound 26 3.293.29 22.9122.91 212212 적색Red 실시예 27Example 27 화합물 27compound 27 3.323.32 22.6522.65 188188 적색Red 실시예 28Example 28 화합물 28compound 28 3.423.42 22.9522.95 228228 적색Red 실시예 29Example 29 화합물 29compound 29 3.333.33 23.3223.32 191191 적색Red 실시예 30Example 30 화합물 30compound 30 3.603.60 20.3420.34 161161 적색Red 실시예 31Example 31 화합물 31compound 31 3.603.60 20.6820.68 152152 적색Red 실시예 32Example 32 화합물 32compound 32 3.543.54 20.8120.81 152152 적색Red 실시예 33Example 33 화합물 33compound 33 3.603.60 21.1921.19 171171 적색Red 실시예 34Example 34 화합물 34compound 34 3.533.53 20.8620.86 153153 적색Red 실시예 35Example 35 화합물 35compound 35 3.563.56 20.7020.70 162162 적색Red 실시예 36Example 36 화합물 36compound 36 3.553.55 20.7120.71 172172 적색Red 실시예 37Example 37 화합물 37compound 37 3.553.55 20.8620.86 156156 적색Red 실시예 38Example 38 화합물 38compound 38 3.603.60 20.4520.45 152152 적색Red 실시예 39Example 39 화합물 39compound 39 3.673.67 19.8719.87 155155 적색Red 실시예 40Example 40 화합물 40compound 40 3.683.68 20.0720.07 153153 적색Red 실시예 41Example 41 화합물 41compound 41 3.643.64 20.0820.08 153153 적색Red 실시예 42Example 42 화합물 42compound 42 3.623.62 20.0620.06 167167 적색Red 실시예 43Example 43 화합물 43compound 43 3.603.60 20.3720.37 157157 적색Red 실시예 44Example 44 화합물 44compound 44 3.613.61 20.4920.49 168168 적색Red 실시예 45Example 45 화합물 45compound 45 3.673.67 19.9019.90 159159 적색Red 실시예 46Example 46 화합물 46compound 46 3.633.63 19.4419.44 170170 적색Red 실시예 47Example 47 화합물 47compound 47 3.653.65 19.8319.83 166166 적색Red 실시예 48Example 48 화합물 48compound 48 3.563.56 20.8620.86 169169 적색Red 실시예 49Example 49 화합물 49compound 49 3.583.58 20.9020.90 170170 적색Red 실시예 50Example 50 화합물 50compound 50 3.563.56 21.0421.04 180180 적색Red 실시예 51Example 51 화합물 51compound 51 3.583.58 21.4521.45 176176 적색Red 실시예 52Example 52 화합물 52compound 52 3.573.57 20.6120.61 168168 적색Red 실시예 53Example 53 화합물 53compound 53 3.603.60 20.4320.43 177177 적색Red 실시예 54Example 54 화합물 54compound 54 3.603.60 21.5021.50 176176 적색Red 실시예 55Example 55 화합물 55compound 55 3.553.55 20.2420.24 177177 적색Red 실시예 56Example 56 화합물 56compound 56 3.353.35 20.4020.40 210210 적색Red 실시예 57Example 57 화합물 57compound 57 3.333.33 21.3721.37 225225 적색Red 실시예 58Example 58 화합물 58compound 58 3.303.30 21.1921.19 227227 적색Red 실시예 59Example 59 화합물 59compound 59 3.433.43 20.8020.80 194194 적색Red 실시예 60Example 60 화합물 60compound 60 3.413.41 20.4420.44 194194 적색Red 실시예 61Example 61 화합물 61compound 61 3.373.37 21.1321.13 212212 적색Red 실시예 62Example 62 화합물 62compound 62 3.313.31 20.7820.78 191191 적색Red 실시예 63Example 63 화합물 63compound 63 3.603.60 20.3820.38 152152 적색Red 실시예 64Example 64 화합물 64compound 64 3.603.60 19.9819.98 166166 적색Red 실시예 65Example 65 화합물 65compound 65 3.653.65 19.4119.41 158158 적색Red 실시예 66Example 66 화합물 66compound 66 3.693.69 20.1020.10 163163 적색Red 실시예 67Example 67 화합물 67compound 67 3.613.61 19.4819.48 170170 적색Red 실시예 68Example 68 화합물 68compound 68 3.603.60 20.1920.19 170170 적색Red 실시예 69Example 69 화합물 69compound 69 3.683.68 20.1020.10 153153 적색Red 실시예 70Example 70 화합물 70compound 70 3.353.35 22.8822.88 212212 적색Red 실시예 71Example 71 화합물 71compound 71 3.283.28 22.9822.98 225225 적색Red 실시예 72Example 72 화합물 72compound 72 3.363.36 22.7322.73 208208 적색Red 실시예 73Example 73 화합물 73compound 73 3.413.41 22.5422.54 211211 적색Red 실시예 74Example 74 화합물 74compound 74 3.353.35 23.1923.19 206206 적색Red 실시예 75Example 75 화합물 75compound 75 3.313.31 23.3123.31 208208 적색Red 실시예 76Example 76 화합물 76compound 76 3.613.61 21.4721.47 154154 적색Red 실시예 77Example 77 화합물 77compound 77 3.563.56 20.6920.69 153153 적색Red 실시예 78Example 78 화합물 78compound 78 3.563.56 21.3321.33 152152 적색Red 실시예 79Example 79 화합물 79compound 79 3.553.55 21.0821.08 165165 적색Red 실시예 80Example 80 화합물 80compound 80 3.563.56 20.8220.82 169169 적색Red 실시예 81Example 81 화합물 81compound 81 3.613.61 21.2621.26 173173 적색Red 실시예 82Example 82 화합물 82compound 82 3.573.57 20.8420.84 157157 적색Red 실시예 83Example 83 화합물 83compound 83 3.583.58 21.2221.22 165165 적색Red 비교예 1Comparative Example 1 화합물 B-1compound B-1 4.09 4.09 18.2018.20 9191 적색Red 비교예 2Comparative Example 2 화합물 B-2compound B-2 4.26 4.26 17.9017.90 7979 적색Red 비교예 3Comparative Example 3 화합물 B-3compound B-3 3.89 3.89 18.8318.83 124124 적색Red 비교예 4Comparative Example 4 화합물 B-4compound B-4 3.75 3.75 18.4818.48 119119 적색Red 비교예 5Comparative Example 5 화합물 B-5Compound B-5 4.12 4.12 17.1017.10 103103 적색Red 비교예 6Comparative Example 6 화합물 B-6Compound B-6 4.07 4.07 18.2918.29 7878 적색Red 비교예 7Comparative Example 7 화합물 B-7Compound B-7 4.05 4.05 18.1718.17 9494 적색Red 비교예 8Comparative Example 8 화합물 B-8Compound B-8 4.04 4.04 17.9517.95 8989 적색Red 비교예 9Comparative Example 9 화합물 B-9Compound B-9 4.06 4.06 18.2218.22 7979 적색Red 비교예 10Comparative Example 10 화합물 B-10Compound B-10 4.11 4.11 18.1818.18 8686 적색Red 비교예 11Comparative Example 11 화합물 B-11compound B-11 4.02 4.02 16.7616.76 103103 적색Red 비교예 12Comparative Example 12 화합물 B-12compound B-12 4.12 4.12 16.9816.98 9292 적색Red

실시예 1 내지 83 및 비교예 1 내지 12에 의해 제작된 유기 발광 소자에 전류를 인가하였을 때, 상기 표 1 내지 표2의 결과를 얻었다. 상기 실시예 1의 적색 유기 발광 소자는 종래 널리 사용되고 있는 물질을 사용하였으며, 전자 차단층으로 화합물 [EB-1], 적색 도판트로 Dp-7을 사용하는 구조이다. When current was applied to the organic light emitting devices manufactured in Examples 1 to 83 and Comparative Examples 1 to 12, the results of Tables 1 to 2 were obtained. The red organic light emitting device of Example 1 used materials widely used in the prior art, and had a structure using compound [EB-1] as an electron blocking layer and Dp-7 as a red dopant.

본 발명의 화합물을 적색 발광층으로 사용했을 때 표 1과 같이 표2의 비교예 대비 구동 전압이 감소하고 효율 및 수명이 증가하는 것을 보아, 본 발명의 화합물을 호스트로 사용했을 때 비교예 화합물 대비 적색 발광층내의 적색 도판트로의 에너지 전달이 잘 이뤄진다는 것을 알 수 있었다. 이것은 결국 비교예 화합물 대비 발광층내로 더 안정적인 균형을 통해 전자와 정공이 결합하여 엑시톤을 형성하기 때문이라 판단할 수 있다.When the compound of the present invention was used as a red light emitting layer, as shown in Table 1, the driving voltage decreased and the efficiency and lifespan increased compared to the comparative examples in Table 2. It was found that the energy transfer to the red dopant in the light emitting layer was well achieved. It can be determined that this is because electrons and holes combine to form excitons through a more stable balance in the light emitting layer compared to the comparative compound.

결론적으로 본 발명의 화합물을 적색 발광층의 호스트로 사용하였을 때 유기 발광 소자의 구동전압, 발광 효율 및 수명 특성을 개선할 수 있다는 것을 확인할 수 있다. In conclusion, it can be confirmed that the driving voltage, luminous efficiency and lifetime characteristics of the organic light emitting device can be improved when the compound of the present invention is used as a host of the red light emitting layer.

1: 기판 2: 양극
3: 발광층 4: 음극
5: 정공주입층 6: 정공수송층
7: 전자차단층 8: 정공저지층
9: 전자주입 및 수송층
1: substrate 2: anode
3: light emitting layer 4: cathode
5: hole injection layer 6: hole transport layer
7: electron blocking layer 8: hole blocking layer
9: electron injection and transport layer

Claims (9)

하기 화학식 1로 표시되는 화합물:
[화학식 1]
Figure pat00119

상기 화학식 1에서,
X1 내지 X10 중 하나는 N이고, 다른 하나는 하기 화학식 2의 치환기가 치환된 C이고, 나머지는 CR1이고,
R1은 각각 독립적으로 수소, 또는 중수소이고,
[화학식 2]
Figure pat00120

상기 화학식 2에서,
Y는 각각 독립적으로 N, 또는 CR2이고, 단 Y 중 적어도 하나는 N이고,
R2는 각각 독립적으로 수소, 또는 중수소이고,
L은 단일 결합, 또는 치환 또는 비치환된 C6-60 아릴렌이고,
L1 및 L2는 각각 독립적으로 단일 결합, 또는 치환 또는 비치환된 C6-60 아릴렌이고,
Ar1 및 Ar2는 각각 독립적으로 치환 또는 비치환된 C6-60 아릴, 또는 치환 또는 비치환된 N, O 및 S로 구성되는 군으로부터 선택되는 어느 하나 이상을 포함하는 C2-60 헤테로아릴이고,
단, X5 또는 X6가 N이면, X1 내지 X4 및 X7 내지 X10 중 하나가 상기 화학식 2의 치환기가 치환된 C이고,
X7 내지 X10 중 하나가 N이면, X1 내지 X6 중 하나가 상기 화학식 2의 치환기가 치환된 C이다.
A compound represented by Formula 1 below:
[Formula 1]
Figure pat00119

In Formula 1,
One of X 1 to X 10 is N, the other is C substituted with a substituent represented by Formula 2 below, and the others are CR 1 ;
R 1 is each independently hydrogen or deuterium;
[Formula 2]
Figure pat00120

In Formula 2,
Y is each independently N or CR 2 , provided that at least one of Y is N;
R 2 are each independently hydrogen or deuterium;
L is a single bond or a substituted or unsubstituted C 6-60 arylene;
L 1 and L 2 are each independently a single bond or a substituted or unsubstituted C 6-60 arylene;
Ar 1 and Ar 2 are each independently a substituted or unsubstituted C 6-60 aryl, or a substituted or unsubstituted C 2-60 heteroaryl containing at least one selected from the group consisting of N, O and S; ego,
However, when X 5 or X 6 is N, one of X 1 to X 4 and X 7 to X 10 is C substituted with the substituent of Formula 2,
When one of X 7 to X 10 is N, one of X 1 to X 6 is C substituted with the substituent of Formula 2 above.
제1항에 있어서,
Y는 모두 N인,
화합물.
According to claim 1,
Y is all N,
compound.
제1항에 있어서,
상기 화학식 1은 하기 화학식 1-1 내지 1-10 중 어느 하나로 표시되는,
화합물:
Figure pat00121

상기 화학식 1-1에서, X2 내지 X10 중 하나는 상기 화학식 2의 치환기가 치환된 C이고, 나머지는 각각 독립적으로 CH 또는 CD이고,
상기 화학식 1-2에서, X1 및 X3 내지 X10 중 하나는 상기 화학식 2의 치환기가 치환된 C이고, 나머지는 각각 독립적으로 CH 또는 CD이고,
상기 화학식 1-3에서, X1, X2 및 X4 내지 X10 중 하나는 상기 화학식 2의 치환기가 치환된 C이고, 나머지는 각각 독립적으로 CH 또는 CD이고,
상기 화학식 1-4에서, X1 내지 X3 및 X5 내지 X10 중 하나는 상기 화학식 2의 치환기가 치환된 C이고, 나머지는 각각 독립적으로 CH 또는 CD이고,
상기 화학식 1-5에서, X1 내지 X4 및 X7 내지 X10 중 하나는 상기 화학식 2의 치환기가 치환된 C이고, 나머지는 각각 독립적으로 CH 또는 CD이고, X6은 CH 또는 CD이고,
상기 화학식 1-6에서, X1 내지 X4 및 X7 내지 X10 중 하나는 상기 화학식 2의 치환기가 치환된 C이고, 나머지는 각각 독립적으로 CH 또는 CD이고, X5는 CH 또는 CD이고,
상기 화학식 1-7에서, X1 내지 X6 중 하나는 상기 화학식 2의 치환기가 치환된 C이고, 나머지는 각각 독립적으로 CH 또는 CD이고, X8 내지 X10은 각각 독립적으로 CH 또는 CD이고,
상기 화학식 1-8에서, X1 내지 X6 중 하나는 상기 화학식 2의 치환기가 치환된 C이고, 나머지는 각각 독립적으로 CH 또는 CD이고, X7, X9 및 X10은 각각 독립적으로 CH 또는 CD이고,
상기 화학식 1-9에서, X1 내지 X6 중 하나는 상기 화학식 2의 치환기가 치환된 C이고, 나머지는 각각 독립적으로 CH 또는 CD이고, X7, X8 및 X10은 각각 독립적으로 CH 또는 CD이고,
상기 화학식 1-10에서, X1 내지 X6 중 하나는 상기 화학식 2의 치환기가 치환된 C이고, 나머지는 각각 독립적으로 CH 또는 CD이고, X7 내지 X9는 각각 독립적으로 CH 또는 CD이다.
According to claim 1,
Formula 1 is represented by any one of Formulas 1-1 to 1-10,
compound:
Figure pat00121

In Formula 1-1, one of X 2 to X 10 is C substituted with a substituent of Formula 2, and the others are each independently CH or CD,
In Formula 1-2, one of X 1 and X 3 to X 10 is C substituted with a substituent of Formula 2, and the others are each independently CH or CD,
In Formula 1-3, one of X 1 , X 2 and X 4 to X 10 is C substituted with a substituent of Formula 2, and the others are each independently CH or CD,
In Formula 1-4, one of X 1 to X 3 and X 5 to X 10 is C substituted with a substituent of Formula 2, and the others are each independently CH or CD,
In Formula 1-5, one of X 1 to X 4 and X 7 to X 10 is C substituted with a substituent of Formula 2, the others are each independently CH or CD, X 6 is CH or CD,
In Formula 1-6, one of X 1 to X 4 and X 7 to X 10 is C substituted with a substituent of Formula 2, the others are each independently CH or CD, X 5 is CH or CD,
In Formula 1-7, one of X 1 to X 6 is C substituted with a substituent of Formula 2, the others are each independently CH or CD, and X 8 to X 10 are each independently CH or CD,
In Formula 1-8, one of X 1 to X 6 is C substituted with a substituent of Formula 2, the others are each independently CH or CD, and X 7 , X 9 and X 10 are each independently CH or is a CD,
In Formula 1-9, one of X 1 to X 6 is C substituted with a substituent of Formula 2, the others are each independently CH or CD, and X 7 , X 8 and X 10 are each independently CH or is a CD,
In Formula 1-10, one of X 1 to X 6 is C substituted with a substituent of Formula 2, the others are each independently CH or CD, and X 7 to X 9 are each independently CH or CD.
제1항에 있어서,
L은 단일 결합, 비치환되거나 또는 하나 이상의 중수소로 치환된 페닐렌, 또는 비치환되거나 또는 하나 이상의 중수소로 치환된 나프틸렌인,
화합물.
According to claim 1,
L is a single bond, unsubstituted or substituted with one or more deuterium phenylene, or unsubstituted or substituted with one or more deuterium naphthylene;
compound.
제1항에 있어서,
L1 및 L2는 각각 독립적으로 단일 결합, 비치환되거나 또는 하나 이상의 중수소로 치환된 페닐렌, 또는 비치환되거나 또는 하나 이상의 중수소로 치환된 나프틸렌인,
화합물.
According to claim 1,
L 1 and L 2 are each independently a single bond, unsubstituted or substituted with one or more deuterium phenylene, or unsubstituted or substituted with one or more deuterium naphthylene;
compound.
제1항에 있어서,
Ar1 및 Ar2는 각각 독립적으로 페닐, 비페닐릴, 터페닐릴, 나프틸, (페닐)나프틸, (나프틸)페닐, 페난쓰레닐, 벤조페난쓰레닐, 디벤조퓨라닐, 디벤조티오페닐, 카바졸-9-일, 또는 9-페닐-카바졸릴이고,
상기 Ar1 및 Ar2는 각각 독립적으로 비치환되거나 또는 적어도 하나의 중수소로 치환된,
화합물.
According to claim 1,
Ar 1 and Ar 2 are each independently selected from phenyl, biphenylyl, terphenylyl, naphthyl, (phenyl)naphthyl, (naphthyl)phenyl, phenanthrenyl, benzophenanthrenyl, dibenzofuranyl, dibenzo thiophenyl, carbazol-9-yl, or 9-phenyl-carbazolyl;
Ar 1 and Ar 2 are each independently unsubstituted or substituted with at least one deuterium,
compound.
제1항에 있어서,
상기 화학식 1로 표시되는 화합물은 하기로 구성되는 군으로부터 선택되는 어느 하나인,
화합물:
Figure pat00122

Figure pat00123

Figure pat00124

Figure pat00125

Figure pat00126

Figure pat00127

Figure pat00128

Figure pat00129

Figure pat00130

Figure pat00131

Figure pat00132

According to claim 1,
The compound represented by Formula 1 is any one selected from the group consisting of
compound:
Figure pat00122

Figure pat00123

Figure pat00124

Figure pat00125

Figure pat00126

Figure pat00127

Figure pat00128

Figure pat00129

Figure pat00130

Figure pat00131

Figure pat00132

제1 전극; 상기 제1 전극과 대향하여 구비된 제2 전극; 및 상기 제1 전극과 상기 제2 전극 사이에 구비된 1층 이상의 유기물층을 포함하는 유기 발광 소자로서, 상기 유기물층 중 1층 이상은 제1항 내지 제6항 중 어느 하나의 항에 따른 화합물을 포함하는 것인, 유기 발광 소자.
a first electrode; a second electrode provided to face the first electrode; and one or more organic material layers provided between the first electrode and the second electrode, wherein at least one of the organic material layers includes the compound according to any one of claims 1 to 6. That is, an organic light emitting device.
제8항에 있어서,
상기 화합물을 포함하는 유기물층은 발광층인,
유기 발광 소자.
According to claim 8,
The organic material layer containing the compound is a light emitting layer,
organic light emitting device.
KR1020220149170A 2021-11-12 2022-11-10 Novel compound and organic light emitting device comprising the same KR20230069848A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202280031945.2A CN117222651A (en) 2021-11-12 2022-11-11 Novel compound and organic light emitting device comprising the same
PCT/KR2022/017711 WO2023085835A1 (en) 2021-11-12 2022-11-11 Novel compound and organic light-emitting device using same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20210155691 2021-11-12
KR1020210155691 2021-11-12

Publications (1)

Publication Number Publication Date
KR20230069848A true KR20230069848A (en) 2023-05-19

Family

ID=86546912

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020220149170A KR20230069848A (en) 2021-11-12 2022-11-10 Novel compound and organic light emitting device comprising the same

Country Status (1)

Country Link
KR (1) KR20230069848A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000051826A (en) 1999-01-27 2000-08-16 성재갑 New organomattalic complex molecule for the fabrication of organic light emitting diodes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000051826A (en) 1999-01-27 2000-08-16 성재갑 New organomattalic complex molecule for the fabrication of organic light emitting diodes

Similar Documents

Publication Publication Date Title
KR102494473B1 (en) Novel compound and organic light emitting device comprising the same
KR102545206B1 (en) Novel compound and organic light emitting device comprising the same
KR102564848B1 (en) Novel compound and organic light emitting device comprising the same
KR102486517B1 (en) Novel compound and organic light emitting device comprising the same
KR102500849B1 (en) Novel compound and organic light emitting device comprising the same
KR20220163908A (en) Novel compound and organic light emitting device comprising the same
KR20230014818A (en) Novel compound and organic light emitting device comprising the same
KR102469106B1 (en) Novel compound and organic light emitting device comprising the same
KR102537419B1 (en) Novel compound and organic light emitting device comprising the same
KR102511932B1 (en) Novel compound and organic light emitting device comprising the same
KR20230012441A (en) Novel compound and organic light emitting device comprising the same
KR102486518B1 (en) Novel compound and organic light emitting device comprising the same
KR102529931B1 (en) Novel compound and organic light emitting device comprising the same
KR102511933B1 (en) Novel hetero-cyclic compound and organic light emitting device comprising the same
KR102564847B1 (en) Novel compound and organic light emitting device comprising the same
KR102549460B1 (en) Novel compound and organic light emitting device comprising the same
KR102463816B1 (en) Novel compound and organic light emitting device comprising the same
KR102573735B1 (en) Novel compound and organic light emitting device comprising the same
KR102500850B1 (en) Novel compound and organic light emitting device comprising the same
KR102469108B1 (en) Novel compound and organic light emitting device comprising the same
KR102602155B1 (en) Novel compound and organic light emitting device comprising the same
KR102541994B1 (en) Novel compound and organic light emitting device comprising the same
KR102419609B1 (en) Novel compound and organic light emitting device comprising the same
KR102415264B1 (en) Novel compound and organic light emitting device comprising the same
KR20230069848A (en) Novel compound and organic light emitting device comprising the same